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Beyond BMI: Conceptualizing Health in the “Obesity Epidemic” 
 
Melanie S. Jeske 
 
 
 
 
 
In June 2013, the American Medical Association (AMA) declared obesity a 
disease. This decision sparked debate both within the medical sphere and among 
the general public. In particular, the AMA was critiqued for making this decision 
against the advice of their delegates charged with disease deliberation, the 
Council on Science and Public Health (CSAPH). The CSAPH advised against 
disease status because of obesity’s reliance on body mass index (BMI). BMI is a 
measurement tool used to classify individuals based on weight and height, 
calculated as weight divided by height squared (W/H2), and has been the 
standard metric for weight classification for since 1977 (Bray, 1979). It is routinely 
criticized as a crude, flawed measure, incapable of providing useful information 
about an individual’s health. Highlighting its limitations, social scientists have 
critiqued BMI as a way to expose obesity research as a problematic field. This 
thesis builds on existing social science literature by moving beyond an external 
critique of the field. That is, this research seeks to understand the field formation 
of obesity research and role of BMI within the field. To do so, I ask three 
overarching questions: 1) when and how did obesity science form in the United 
States? 2) how do obesity researchers make sense of obesity’s label as both a 
disease and epidemic? and 3) how does BMI operate, and with what meaning(s), 
in clinical research settings? Following qualitative methods of grounded theory 
(Corbin & Strauss, 2008; Strauss & Glaser, 1967) and situational analysis (Clarke, 
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2005), this thesis utilizes content analysis of historical and contemporary medical 
literature on obesity and the development of BMI, in depth interviews with 
prominent obesity researchers, and participant observation at ObesityWeek 2014.  
Chapter 1 provides an introduction to social science scholarship on obesity and 
sets the stage for a science and technology studies (STS) approach to obesity 
science. Chapter 2 builds on field formation literature to explore the 
development of obesity research as a knowledge field. It articulates rhetorical 
strategies used to expand and sustain the field and some of the obstacles obesity 
research faces as a multidisciplinary knowledge field. Chapter 3 hones in on the 
role of BMI in obesity research from its formation to the contemporary area. It 
illustrates how BMI has been come a stabilization tool within the field, despite its 
limitation as a measurement tool; how researchers make sense of BMI in their 
clinical work; and some of the ways in which BMI’s framing power influences 
research design. Finally, Chapter 4 brings forward three main conclusions of this 
thesis. In short, “Beyond BMI: Conceptualizing Health in the ‘Obesity 
Epidemic’,” argues that 1) BMI serves as a crucial tool for the field of obesity 
science to stabilize its multiple disciplines, standardize research and bodies, and 
to articulate adiposity’s risks and health complications, 2) obesity’s framing as 
complex enables scientists to defend abnormalities in research findings without 
disrupting the BMI paradigm and to justify continued research investment and 
diversification of the field, and 3) meta-level problematic framing of the obese 
condition impacts obesity researchers' willingness to accept more complex 
relationships between obesity and health.
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Chapter 1: The Case for a Science Studies Approach 
 
In June 2013, the American Medical Association (AMA) designated obesity a 
disease (AMA, 2013). Although obesity has been considered a health concern and 
a risk factor for cardiovascular and metabolic diseases for decades (Keys et al. 
1972, Bray, 1975), the designation of obesity as a “disease” was hotly contested. 
Critics argued that the AMA’s decision was misguided for several reasons: 
public health practitioners and social scientists worried that it would remove 
pressure from Big Food and government to change their food production, 
marketing, and subsidy policy (Nestle, 2003; Biltekoff, 2013; Guthman, 2011; 
Oliver, 2006); physicians noted that obese individuals might feel hopeless and 
lose motivation to lose weight (Allison et al. 2008); fat activists urged for fat 
acceptance and against the medicalization of fat (Boero 2013; LeBesco, 2010). 
Perhaps the most salient critique, echoed by various stakeholders, challenged the 
very core of how obesity is defined in clinical practice. In fact, the delegates 
charged with deliberating disease designation, the Council on Science and Public 
Health (CSAPH), advised the AMA against elevating obesity to disease status 
because of its definition’s reliance on the body mass index (CSAPH, 2012).  
Body mass index (BMI) is a measurement tool used to classify individuals 
based on weight and height, calculated as weight divided by height squared 
(W/H2).  BMI thresholds are used to determine whether an individual is within 
the normal weight range and, if not, how far from the normal weight the person 
deviates.  Established in 1998, current National Institutes of Health (NIH) 
guidelines classify adults overweight and obese at BMIs of 25.0 and 30.0 
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respectively, regardless of sex.  For adolescents, BMI-based categorization 
schemes are slightly more sophisticated, taking into account age and sex and 
divided into percentiles. These distinctions are made because children’s body 
composition varies as they age and based on their sex (CDC, 2012). For 
adolescents overweight and obese are defined for sex and age as falling above 
the 85th and 95th percentiles, respectively.  
Despite the impression of certainty that emerges through the use of 
measurement and statistics, scientists remain skeptical about BMI’s value as a 
predictor of an individual’s health. In its 2012 report to the AMA, for example, the 
CSAPH concluded:  
[G]iven the existing limitations of BMI to diagnose obesity in clinical 
practice, it is unclear that recognizing obesity as a disease, as opposed to a 
“condition” or “disorder,” will result in improved health outcomes.[…] 
What is clear is that a better measure of obesity than BMI alone is needed 
(CSAHP, 2012, p. 6). 
 
Although it is routinely criticized within and outside the expert community, BMI 
has come to be regarded as what Clarke and Fujimura call “the right tool for the 
job” (1992). Annually, over $800 billion in public funding is allocated toward 
studying the causes, prevention, and treatment of obesity with BMI being used to 
demarcate normal weight versus obese conditions (NIH, 2015). In the media, 
obesity is blamed for annual health costs to our nation in the order of $147 billion 
(Gruber, 2012); 1 in 3 Americans (AMA, 2013) is deemed problematic and 
unhealthy (Boero, 2013); entire industries are founded on the insatiable demand 
for weight reduction (Dworkin and Wachs, 2009); and minority populations are 
surveilled more than others (Guthman, 2011; Boero, 2013). Obesity is considered 
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a public health crisis and an epidemic threatening various aspects of life 
including children’s life expectancy (CDC, 2012), economic productivity (Gruber, 
2012), and national security (Gruber, 2012).  All of these claims and mobilizations 
rely on the use of BMI to categorize bodies into normal weight, overweight, 
obese. 
Social scientists highlight BMI’s political mobilization, flaws, and 
historical roots to justify their efforts to expose the “obesity epidemic.” Despite 
this critique, obesity experts maintain that BMI is a useful measurement tool for 
population health. It is useful at the population level, for example, to predict 
comorbidities (Type II diabetes, asthma, sleep apnea, and cardiovascular disease) 
and to identify geographic areas with substandard health infrastructures 
(Akabas et al., 2012). That said, scientists concede that BMI measures are not 
predictive at the individual level. That is, BMI is not always indicative of health 
concerns, particularly among those who are classified as overweight or Class I 
obesity (BMI ranges 25.0-29.9 and 30.0 – 34.9 respectively) and still considered 
metabolically healthy by other metabolic indicators (i.e. blood pressure, 
cholesterol, and glucose levels). Thus determining whether BMI is an appropriate 
measure is context dependent, and the ways obesity researchers use BMI (and 
the meanings it is assigned) fluctuate within both the expert community and the 
public sphere. Asking questions about why BMI became the indicator of choice, 
how it operates in research settings, and what meanings it accrues is important 
for understanding how obesity is socially constructed. Yet a social scientific 
study of the rise of obesity science and the assumptions that guide this work has 
not yet occurred.  
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BMI’s limitations have been well documented in both contemporary 
research and in studies conducted before the rise of the obesity research 
enterprise and obesity prevalence in the US population (Keys et al., 1972). Such 
imperfections include the classification’s inability to predict health at the 
individual level, its incapacity to detail the biological health of the body, lack of 
correlation to body density, and the measurement problems with sampled 
populations (Bray, 1979; Jarrett, 1986; Keys et al., 1972, 168). BMI has been 
promoted for its computational ease and low cost compared to more precise 
measurements of body fat. By the same token, BMI’s minimal input requirements 
yield an output with little value. Glance at any clinical research, news media, or 
health campaign about obesity and you will find a disclaimer regarding BMI’s 
limitations. The ubiquitous disclaimer, which tends to read along the lines of “an 
imperfect measure,” acknowledges the experts’ admission of the indicator’s 
limitations while maintaining that despite such limitations, BMI still provides 
some use in predicting health risks and population health outcomes. In this way, 
such acknowledgment enables researchers and health authorities to circumvent 
any real engagement with prevailing critiques of BMI. As I will articulate in 
Chapter 3, BMI’s publicly acknowledged flaws—which can be manipulated to 
serve researchers’ purposes—actually contribute to its power as a tool. 
In light of such strong critique, many social science scholars have 
questioned the obesity research enterprise. Obesity has been deemed an 
epidemic, made visible by BMI categorizations. And despite its clear limitations, 
BMI has evolved into a leading health indicator in global health (Boero, 2013; 
Campos et al., 2006; Oliver, 2006). Most recently through disease status 
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affirmation by the AMA in 2013, BMI has been granted authority to determine 
the diseased and the healthy.  
1.1 Social Science Approaches to Obesity 
It is fitting, then, that sociologists, anthropologists, political scientists, and critical 
geography scholars have directed their efforts toward BMI’s limitations, often 
highlighting the health politics that are deeply entrenched in social 
understandings of obesity (Biltekoff, 2013; Boero, 2013; Campos, 2004; Guthman, 
2011; LeBesco, 2010; Oliver, 2006). They emphasize how the medicalization of 
one’s weight shifts attention away from the structural mechanisms that play a 
role the accumulation of adipose tissue (i.e. the food environment, neoliberalism 
and the food industry, poverty and food access). These are worthy critiques that 
operate at the macro level of social organization and market forces (Fortun, 
2009).  In some cases, social science scholars agree that obesity is a problem—but 
that society is incorrectly handling it (Biltekoff, 2013; Campos, 2004; Oliver, 
2006). Such studies call on policy makers and governments to intervene in the 
food market, nutrition and exercise education guidelines, and the design and 
management of built environments. Other scholars question whether obesity is 
actually a problem (Boero, 2013; LeBesco, 2010); instead they urge for fat 
acceptance and critique the shrinking definition of normal.  
Much of the existing social science research on obesity is rooted in 
medicalization and biomedicalization theory (Zola, 1972; Clarke et al., 2003, 
Clarke et al., 2010; Conrad, 2005; Conrad, 2007; Conrad & Schneider, 1992).   In 
“Medicalization as an Institution of Social Control,” Irving Zola described the 
medicalization revolution that created ‘medical governance’ in the early 1970s.  
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Medicalization described the physician’s expansion from merely the exercise of 
technical skills to extend into the lives of patients through diet, lifestyle, and 
moral prescriptions (Zola, 1972, p. 493).  Clarke et al. and Conrad’s recent work 
builds upon medicalization literature (Conrad, 2007; Zola, 1972) and theories of 
biopower (Foucault, 1979), carrying medicalization into the emerging era of 
biomedicine. In “Biomedicalization: Techonoscientific Transformations of 
Health, Illness and U.S. Biomedicine,” Clarke et al. describe the shift from 
medicalization (Zola, 1972) to biomedicalization post 1985 (Clarke et al., 2003, p. 
161). Clarke et al. describe the current technoscientific revolution, the shift from 
medicalization to biomedicalization, as a “shift from enhanced control over 
external nature to the harnessing and transformation of internal nature (Clarke et 
al., 2003, p. 164).” They claim biomedicalization is co-constituted through five 
key processes: 1) political economic shifts, 2) a new focus on health, risk, and 
surveillance biomedicines, 3) technoscientization, 4) transformations of 
production, distribution, and consumption of biomedical knowledges, and 5) the 
transformation of bodies and identities (Clarke et al., 2003, p. 166).  
 The second and fifth processes help us to understand the explosion of the 
health, weight loss, and fitness industries beginning in the late 1980s and thus 
the moral framing of obesity.  Unique to biomedicine is the idea of ‘health’ itself. 
The focus on health, risk, and surveillance creates health “as an individual goal, a 
social and moral responsibility, and a site for routine biomedical intervention 
(Clarke et al., 2003, p. 171).”  Rather than a balanced, natural state, biomedicine 
positions health as a state that we must continually work toward.  To achieve this 
goal, self-discipline and risk surveillance are imperative; there is always a risk of 
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falling ill (Clarke et al., 2003, p. 172-173). This notion has serious implications for 
obesity. Not only are obese people deemed morally inferior (Saguy, 2012), the 
overweight or obese person is framed as unhealthy amidst an ever-shrinking 
definition of health. As Zola claims, “locating the source and the treatment of 
problems in an individual, other levels of intervention are effectively closed” 
(Zola, 1972, p. 500).   
 Also identifying changes in medicalization processes, Peter Conrad asserts 
that we have experienced a shift in the engines that drive medicalization toward 
biotechnology, consumers, and managed care systems (Conrad, 2005).  In his 
work, Conrad calls social scientists to “refocus the sociological eye” (2005).  
Responding to Conrad, Clarke, and social scientists who have engaged the 
obesity epidemic, this study proposes to refocus the sociology of obesity through 
a science studies approach—specifically calling attention to how standardization 
and measurement tools and the social world of obesity science research interact 
with and influence the engines of (bio)medicalization.  
Existing social science obesity literature spans four broad areas: morality 
and social stigma (Jutel, 2006; Boero, 2013; Saguy, 2012; Saguy & Gruys, 2010; 
Saguy & Riley, 2005; Saguy & Ward 2011), the food environment (Biltekoff, 2013; 
Nestle, 2003; Oliver, 2006), role of the health/fitness and weight-loss industries 
(Dworkin and Wachs, 2009; Salant & Santry, 2006; Throsby, 2007) and health 
disparity (Delgado, 2013; Guthman, 2011). These studies point to the social, 
environmental, and economic entanglements at the root of America’s perceived 
obesity problem.  Whether their analyses focus on causation, perception, or 
problematization of obesity, these scholars conclude that metal-level framing of 
   
 
 
 
8 
the obesity epidemic is social. None of these scholars has engaged directly with 
scientific obesity research. Their starting point is that obesity exists rather than how 
obesity is enacted, what obesity means, and why, when, and in what circumstances 
obesity matters.  These questions are situated at a much more granular level, one 
that is certainly influenced by, but not encompassed by, the meta- and macro-
level forces others have theorized. This thesis opens the black box of obesity 
research, investigating what obesity means to obesity scientists and the role BMI 
plays in the construction of obesity science.  
1.2 A Science Studies Approach 
 
Utilizing a science studies lens, I ask the following questions:  
• When and how did scientific obesity research form in the United States? 
 
• How does interdisciplinarity and multidisciplinarity work in obesity 
science?  
 
• How do obesity researchers make sense of obesity’s label as both a disease 
and epidemic?  
 
• How does BMI operate, and with what meaning(s), in clinical research 
settings? 
To produce a thick analysis of the social world of obesity science, this study 
utilizes situational analysis. Situational analysis is a theory/methods approach 
that enhances traditional grounded theory, incorporating postmodern 
understandings of identity, scholarship, and society. Situational analysis 
supplements and complements traditional grounded theory, bringing it around 
the postmodern turn (Clarke, 2005). Grounded theory methodology is an 
inductive, qualitative approach to research in which researchers develop code, 
diagrams, and memos to find themes and concepts from data (Corbin & Strauss, 
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2008; Glaser & Strauss, 1967). Situational analysis adds to grounded theory 
methodology by drawing attention to the nonhuman, recognizing power 
relations (introducing Foucault to Strauss’s theory/methods package), and 
calling attention to the social world rather than human action alone.  Situational 
analysis also encourages mapping of social situations as a modification to 
Strauss’s diagramming, paying particular attention to institutions, controversies, 
and stakeholders. Clarke argues that multi-sited research “opens up what 
constitutes the research situation. It brings us closer to the messy complexities 
that constitute ‘life itself’” (Clarke, 2005, p. 171).  
This study draws on four methods conducted concurrently: content 
analysis of obesity research publications and textbooks, historical textual 
discourse analysis to investigate BMI’s history, in-depth interviews with obesity 
researchers and clinicians, and participant observation at scientific obesity 
conferences. First, content analysis was conducted on clinical research 
publications between 2010 and 2014. This time period encapsulates the release of 
the 2011 Strategic Plan for NIH Obesity Research and the American Medical 
Association’s official disease designation in 2013. These events are significant for 
two reasons: the NIH strategic plan guides what research will be funded and 
how researchers should gear their work, and the AMA designation changes 
financial implications of obesity prevention and treatment, justifying continued 
research funding and increasing momentum for pharmacotherapy. Content 
analysis was also conducted using three obesity textbooks, Textbook of Obesity: 
Biological, Psychological and Cultural Influences edited by Sharon R. Akabas, Sally 
Ann Lederman, and Barbara J Moore, Obesity: Etiology, Assessment, Treatment and 
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Prevention by Ross Anderson, and Practical Manual of Clinical Obesity by Robert 
Krushner, Victor Lawrence, and Sudhesh Kumar, to determine how BMI, 
obesity, and health are conceptualized, to map the field of research, and for 
general education about the physiological mechanisms of obesity.  
Institutional publications, press releases, policy statements, and 
conference proceedings from prominent institutions have also been analyzed. 
Such institutions include the American Medical Association, John E. Fogarty 
International Center for Advanced Study in the Health Sciences, US Department 
of Health and Human Services and National Institutes of Health. Each of these 
institutions has played an integral role in in the evolution of the obesity 
epidemic, framing obesity as a major public health concern and promoting 
obesity as a leading health indicator. Second, thirteen in-depth interviews were 
conducted with prominent obesity researchers in the fields of internal medicine, 
clinical psychology, public health, bariatric surgery, pediatrics, neuroscience, and 
metabolic biology. Finally, participant observation was conducted at the 
prominent annual ObesityWeek conference, held in Boston, MA in 2014. 
ObesityWeek is the predominant scientific conference for obesity researchers. 
Held annually, ObesityWeek is co-hosted by The Obesity Society and The 
American Society for Metabolic and Bariatric Surgery. Conference participants 
and presenters include researchers in the fields of public health, internal 
medicine, metabolic biology, and neuroscience, along with physicians, bariatric 
surgeons and dieticians, health policy makers, and pharmaceutical 
representatives. 
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1.3 Contributions to Science and Technology Studies (STS) Literatures 
 
This research expands three areas of science and technology studies scholarship. 
First, this study takes the field of obesity science as the object of study 
(Oudshoorn, 1994; Oudshoorn, 2003; Clarke, 1998; Frickel, 2004). STS scholars 
focus on the social forces that give rise to new fields, research questions, and 
content. Drawing on Fortun’s (2009) understanding of scale, this research 
contributes to the STS and sociological literature on field formation by paying 
particular attention to the cultural contexts and technologies of measurement 
used to justify and standardize scientific practice. Second, this work contributes 
to literature on technology of standardization. Third, this work adds to 
biomedicalization literature, demonstrating the role obesity science plays in 
biomedicalization processes. By putting both obesity research and the 
deployment of BMI at the center of the analysis, this research demonstrates 1) 
how obesity research agendas have defined and transformed obesity overtime to 
shift scientific understanding from simple notions of energy imbalance to a 
complex condition in need of multidisciplinary solutions, 2) how researchers 
interpret findings to enact risk, surveillance, and technoscientization, and 3) how 
disease status increases the economic activities and actors involved in the 
political economy of obesity. 
1.3.1 Fields Formation and Diversification of Obesity Science 
 
Though obesity has been declared an epidemic in only the past thirty-five years 
(Bray, 1979) and a disease within the past two, the field of obesity research has 
been growing for over fifty. Obesity in Perspective (1975) and Obesity in America 
(1979) are two of the earliest publications describing research on the causes, 
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implications, and treatments of obesity.  Published following national 
conferences of obesity-related task forces in October of 1973 and 1977, Obesity in 
Perspective and Obesity in America laid the foundation for contemporary scientific 
developments. Perhaps most striking about Obesity in America is the authors’ 
foresight of the heterogeneous nature of obesity; a conclusion which at once 
complicates our understanding of the obese condition and necessitates a larger 
research force for combating its existence.  
Over forty years and trillions of public dollars later, debates still surround 
causation, treatment, and prevention because of prevailing beliefs about the 
nature of obesity. As will be discussed in depth in Chapter 2, as the obesity 
research enterprise developed and expanded, its multidisciplinary roots have 
created tension within the scientific community. Scientists from different 
disciplines ascribe to different theories for causation and treatment and these 
beliefs deeply guide their work, often to the dismay of other experts.  
This research contributes to the STS literature on field formation by 
investigating the values embedded in BMI measurements and by examining how 
BMI is used to standardize obesity science across fields. To do this, I draw on 
anthropologist and STS scholar Kim Fortun’s (2009) notion of scale as a heuristic.   
Utilizing the seven layers theorized by Fortun (2009), this study unpacks 
the cultural layers of obesity science and understand how social values permeate 
the field. Incorporating social elements specific to obesity, we can apply Fortun’s 
seven layers as follows: 
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• Meta level (dominant discourse1): Cultural perception of the obesity 
epidemic, metaphoric language of war, moral outrage (Boero, 2013; 
LeBesco, 2010; Saguy, 2013); 
 
• Macro level (translocal institutions, law, markets): Health politics, American 
Medical Association official designation of disease status (American 
Medical Association, National Institutes of Health and Department of 
Health and Human Services, Centers for Disease Control and Prevention 
(Boero, 2013; Campos, 2004; Lupton, 2013; Oliver, 2006); 
 
• Meso level (social organization and interaction): perceived healthcare 
implications and costs (Campos, 2004), research agendas, national 
campaigns and task forces; 
 
• Micro level (level of practice): public health authority campaigns (Boero, 
2013), physician intervention (Frank, 1998), fitness programming 
(Dworkin & Wachs, 2009); 
 
• Nano level (subjectivity and subject formation): fat stigma (Saguy, 2013; Saguy 
and Gruys, 2011), fat experience (McCullough & Hardin, 2013), fat 
identity (LeBesco, 2010); 
 
• Technological level (technological infrastructure): measurement, 
pharmaceutical development, surgical enterprise; 
 
• Metaphoric Ground (stuff): adipose tissue, pathway transformation, 
population body. 
 
Attending to both the technological and metaphoric ground levels, this thesis 
adds to field formation literature by theorizing how cultural values and problem 
framing of the obesity epidemic permeates the science and practice of obesity 
researchers (Guthman, 2011).  It also helps highlight the sociality of BMI, 
demonstrating how it is a social technology of measurement and a technology of 
standardization.  
                                            
1 Fortun clarifies the meta-level as the organization of what is used, compared, and considered of 
interest. The meta-level thinking does not encompass the lower strata but rather shapes it without 
determining thought and behavior (Fortun, 2009, p. 76). 
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1.3.2 Biomedicalization: Risk & the Economics of Obesity  
 
The recent labeling of obesity as a disease and increasing investment in 
intervention and prevention campaigns can be understood as part of the shift 
toward biomedicalization: obesity treatment has shifted toward a focus on risk, 
health, and surveillance along with the technoscientization of biomedicine 
through pharmacotherapy and bariatric surgery options (Clarke et al., 2003). The 
updated Strategic Plan for NIH Obesity Research released in 2011 signaled a shift 
in research agenda. Whereas the first strategic plan, released in 2004, highlighted 
a need for behavioral and medical intervention and treatment, the 2011 update 
focused on increased granularity, epigenetic influences, biological process 
disruption, and prevention strategies. This shift matters because outcome- and 
evidence-based research directly influences public health campaigns and 
strategies.  
Second, obesity research and the cultural framing of the “obesity 
epidemic” are entangled with economic relations. The field of obesity science 
cannot be understood without an examination of the economic organization and 
relationships that emerge through the existence and implications of obesity. The 
existence of obesity enables the creation of plus-size or oversized industries and, 
as many argue, sustains certain sectors of the food industry (Oliver, 2006; Nestle, 
2003). Problematizing obesity creates and sustains the weight loss industry, the 
market for “diet” and “low calorie” foods, fitness industries, the bariatric surgery 
industry and the field of obesity research more broadly.  Beyond these macro 
level relationships, obesity contributes to several other economic conversations.  
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Currently, obesity is blamed for unproductivity, missed days of work, and 
elevated healthcare expenditures amounting to an estimated $147 billion 
annually (Gruber 2012; HBO & IOM, 2012). Such arguments are often challenged 
by anti-obesity activists. At the same time, declaring obesity a disease has direct 
economic implications. Obesity has been considered a lifestyle issue or a 
preventative health issue by health insurance companies and therefore there was 
no reimbursement for obesity-related expenditures. However with disease 
status, insurance providers are pressured to cover nutrition, weight loss, and 
lifestyle counseling along with other weight-related care (Allison et al., 2008; 
CSAPH, 2012). This research contributes to the STS literature on 
biomedicalization by showing how disease status becomes an economically 
valuable status and by critically examining how biomedicalization has shifted 
the agenda of obesity research from external treatment toward harnessing the 
internal workings of the body (Clarke et al., 2003).  
1.4 Outline of the Thesis 
Each chapter of this thesis contributes to my overarching analysis of obesity 
research but can be read independently as a series of diffractions (Haraway 1997; 
Joyce, 2006). Diffractions “evoke both the process and the effect of social 
investigation” (Joyce, 2006, p. 19). Chapter 2, “Gaining Weight: Field Formation 
and the Expansion of the Scientific Enterprise of Obesity Research” provides an 
account of obesity research’s historical development as a knowledge field, 
detailing the scientific organizing and mobilization. Analysis for this chapter 
draws on semi-structured interviews conducted with senior members of the 
scientific community, content analysis of historic conference proceedings and 
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health authority reports. Drawing from fields formation literature, this chapter 
provides an account of the rise of the obesity research enterprise. Second, I 
articulate the enterprise’s reliance on rhetorical strategies to promote obesity as a 
complex condition in need of multidisciplinary intervention strategies. I argue 
that this strategy helped lay the foundation for the diversity of fields that 
constitute the field of obesity science. Across disciplines, experts disagree about 
the causes and treatments of obesity. Thus, Chapter 2 discusses the internal 
conflicts that have been produced by, and reproduce, the field’s struggle for 
legitimacy and multidisciplinary composition.  
Chapter 3, “Standardizing Adiposity, Categorizing Bodies: BMI as a 
Technology of Calibration” analyzes how BMI operates in obesity research, what 
meanings it accrues, and how its utilization shapes research agendas. Drawing 
on content analysis of historical studies on BMI, semi-structured interviews, and 
participant observation data, I argue that BMI serves as a stabilizer for a diverse 
field of experts, and that while BMI does not constitute our knowledge about 
adiposity, it does provide a powerful frame that affects how we understand our 
relationship with accumulated adipose tissue and body size.  Moreover, the 
oversimplification that occurs when scientific obesity research is translated to 
public health and medical intervention has far-reaching consequences not only in 
how we shape obesity research, but also how we perceive bodies, ourselves and 
health. BMI is not an indicator with the capacity to detail the biological; it is a 
technology that necessarily oversimplifies complex biological relationships while 
simultaneously assuming the role of a health indicator.   
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The concluding chapter, “Rethinking Obesity: Consequences of 
Biomedicalization” brings the three main conclusions of “Beyond BMI: 
Conceptualizing Health in the Obesity Epidemic” forward. First, I argue that 
BMI has served as a crucial tool for the field of obesity science to stabilize its 
diverse disciplines, standardize research and bodies, and to articulate adiposity’s 
risks and health complications. Thus, BMI continues to carry authority despite its 
well-known limitations. Second, obesity's framing as complex enables scientists 
to defend abnormalities in research findings without disrupting the BMI 
paradigm and to justify continued research investment and diversification of the 
field. Third, meta-level problematic framing of the obese condition impacts 
obesity researchers' willingness to accept more complex relationships between 
obesity and health.  
Within the scientific community BMI does not hold truth-telling power, 
but when translated to the public, a slippage often occurs. As historian Theodore 
Porter notes, the standardization and simplification of complex expressions may 
increase an indicator’s transferability and usefulness, but often at a societal cost 
(Porter, 1995). Understanding the roots of this acceptance—the institutional 
actors, training of practitioners, and occupational reward systems—has 
implications for social justice. This work has the potential to reopen 
conversations about the social inequalities correlated with overweight and obese 
populations which disproportionally affect women, minorities, and low income 
earners (Guthman, 2011; Boero, 2013; Delgado, 2013). It can also help members of 
society to navigate what such labels mean in the context of their individual 
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health and to question the knowledge produced on obesity management in an 
increasingly commodified health market.  
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Chapter 2: Gaining Weight: Field Formation and the Expansion of the 
Scientific Enterprise of Obesity Research 
 
The word obesity is derived from ob, over, and edere, to eat, carrying with it the 
centuries-old assumption that obesity is a single entity due to the single cause of 
overeating. Only in the last twenty years has evidence begun to accumulate 
which contradicts this unitary concept. Most clinical and epidemiological 
investigations still use obesity in its old context, as if it were a single condition 
caused by self-indulgence. However, the perpetuation of this assumption can 
distort our observations in regard to pathogenesis and risks, confound our 
approaches to treatment, and confuse our ability to think about priorities in 
research and public action. (Sims 1979, p. 20) 
 
This chapter discusses the field formation of obesity research, focusing on its 
social organization, rhetorical strategies, and need for stabilizing metrics. I argue 
that the framing of obesity as a heterogeneous and complex condition, as 
articulated in Sims’ quote above, was and remains crucial to establishing obesity 
as a field of legitimate scientific inquiry, securing research funding, and 
justifying field expansion. Second, I contend that conflict emerges from the 
multidisciplinary organization of the research arena, highlighting the ways in 
which the adoption of a stabilization tool, BMI, has been instrumental in creating 
shared rules of understanding within the field and also to translating the 
pragmatic import of scientists’ work to government and the public.  
2.1 Field Formation Literature 
 
Science and technology studies literature does not take the emergence of new 
scientific research areas or fields as neutral, or as arising only from “good” 
science. Instead, the creation of new research areas and fields are understood as 
social practices—ones that are shaped by cultural contexts, stakeholders, and 
networks. This chapter builds on existing field formation theory (Bourdieu, 1996, 
1998; Clarke, 1998; Frickel, 2004; Frickel & Moore, 2006; Martin, 2003; 
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Oudshoorn, 1994; Oudshoorn, 2003; Shostak, 2013). Fields theory is an analytic 
approach that attends to the “forces and struggles within fields” (Shostak, 2012).  
Scholarship on strategic action fields calls attention to four aspects of a field:  
• What is at stake in the field; 
• The actors and their power; 
• Shared understandings of the rules of the field; and 
• An interpreted frame that actors (individual and collective) use to make 
sense of the field (Shostak, 2012). 
 
In Sara Shostak’s (2013) work, attention is paid to the broader social arena in 
which strategic action fields are situated. She writes,  
[F]ields do not exist in a vacuum; relationships and boundaries with other 
fields are often powerful parts of a field’s developmental history. Insofar 
as we fail to attend to the ties that link fields to each other—and to the 
broader field environment in which they are located—we constrain our 
ability to understand field dynamics (Shostak, 2013, p. 9). 
 Paying attention to the larger arena (broader field environment) is imperative to 
understanding the dynamics of obesity research. Both external forces and 
interactions (such as a booming weight loss and fad dieting industry, along with 
a cultural trend of moralizing health) and the internal conflicts that arise where 
disciplinary boundaries meet have strongly shaped the field’s development. 
Tracing the structures and processes of decision-making, the 
organizational model of the scientific movement comprised of obesity 
researchers, and the production of knowledge on obesity are complex issues. 
These issues are made more complex because obesity research is situated 
similarly to an “interdiscipline.” An interdiscipline is, as Frickel writes,  “a 
knowledge field that maintains itself through regular and purposeful interaction 
with other fields and other domains” (Frickel, 2004, p. 5), which in turn brings in 
more actors, epistemologies and professional norms. In his study of the rise of 
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genetic toxicology, Frickel argues that the establishment of genetic toxicology 
was driven by a “scientists’ social movement” comprised of a committed group 
of scientists concerned about chemical mutagens.  In this chapter, I draw on 
interviews with senior obesity researchers and content analysis of conference 
proceedings and health authority documents to examine the mobilization of 
scientific obesity researchers into what Frickel (2004) terms, a scientific social 
movement.   
 Political scientists and political sociologists typically understand social 
movements as collective action that organizes in response to some grievance, 
demanding social or political change. Social movements stand in opposition to 
well-established institutions; the movement is the outsider (Tarrow, 1989). 
Traditional understandings of social movements, then, reject the concept of a 
scientific social movement because at a surface level, science appears 
uncontentious. It does not appear to respond to a grievance or demand political 
or social change. Taking on more traditional theories of social movements, 
Frickel’s work argues that scientist activism can take unexpected forms; although 
scientists do not lack institutional access as social movements tend to (Frickel, 
2004, p.14), theorizing through the social movements literature has much to offer 
analytically. That is, we can learn about scientific social movements from both 
how they are influenced by external societal forces and by theorizing how the 
dynamics of new sciences express important similarities with the dynamics of 
other types of social movements2 (Frickel 2004). Following a science studies 
                                            
2 Frickel borrows from both the social-shaping perspective and the movement-as-metaphor 
perspective from social theory to examine the rise of genetic toxicology as a scientific social 
movement. 
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perspective, Frickel demonstrates how social movements in science do address 
challenges and effect political change, although they may not initially appear to 
address a grievance or elicit political or social change.  In the case of genetic 
toxicology, scientist activists acted on their concern of chemical mutagens and 
were able to use growing concern for the environment among the general public 
and scientific institutions to carve the new discipline of genetic toxicology.  
Obesity scientist activism diverges from genetic toxicology in that much of 
the public awareness about obesity was generated by the clinical researchers and 
scientists studying obesity. In the case of the obesity scientific social movement, 
researchers were effectively brought about public awareness of the risks 
associated with obesity and policy change, but have been ineffective in efforts to 
alter environments that foster obesity, or what are called “obesogenic” 
environments. Division within the scientific community about research agendas 
has created conflict within the field. Scientists, while perhaps not facing 
institutional challenges in the traditional sense, did certainly face an uphill battle 
in their efforts to convince the scientific community that obesity is a complex 
entity, a societal challenge, and a legitimate field of research.  
Like Frickel’s analysis of genetic toxicology, imagining obesity research as 
a scientific social movement can be fruitful to deepen our understanding of the 
institutional politics and social dynamics at play. While Boero’s (2013) 
characterization of obesity researchers as “moral entrepreneurs” highlights 
certain dynamics of the medicalization of obesity, I show how obesity 
researchers mobilized the field of obesity science by connecting with researchers 
across the globe, institutionalized their knowledge field through creating 
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journals and research centers, and negotiated conflicting perspectives on the 
obese condition to eventually achieve disease status. 
2.2 Coalescing a Scientific Movement: From a Scientific Bandwagon to a 
Scientific Enterprise 
 
While many scientists, particularly in the United States and in the United 
Kingdom, were studying obesity from the 1920s to the 1960s, there was no 
organized network of researchers nor were there dedicated institutional 
structures such as professional organizations or journals (Bray, 2015). To counter 
this lack of structure, prominent obesity researchers, including US based Dr. 
George Bray, an endocrinologist by training, and UK based internist Dr. Alan 
Howard, made a serious effort to formalize obesity research in the late 1960s and 
into the 1970s. To do this, they took advantage of a recent development in the 
National Institutes of Health. In 1968, the NIH was granted funds to open the 
John E. Fogarty International Center for Advanced Study in the Health Sciences. 
Named after John E. Fogarty, a congressman who advocated for the NIH 
funding and who died in 1967, the Fogarty International Center (FIC) is the arm 
of the NIH that seeks to advance global public health (NIH 2015).  After it was 
established, the FIC hosted a series of conferences focused on emerging issues in 
global health. The first, held in 1971, concentrated on diabetes, The next two, in 
1973 and 1977, focused on obesity (Fogarty, 2012).  
To institutionalize the field, Drs. Bray and Howard organized the two 
Fogarty International Conferences (FIC) and created an obesity specific journal, 
the International Journal of Obesity (IJO), which published its first issues in 1977 
with Drs. Bray and Howard as the founding editors. The Fogarty International 
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Conferences (FIC) served two main functions. First, they served to bring 
scientists from around the world who were studying obesity to one place. 
Second, the FICs set the stage for the obesity research agenda, a point that will be 
further developed in Chapter 3. In addition to the conferences and establishing 
the IJO, George Bray and colleagues created the North American Association for 
the Study of Obesity (NAASO) during the 1970s to expand the scientific 
community and further establish obesity research as a field.  NAASO held its 
first conference in 1982 at Vassar College (Bray 2015). Finally, plans for 
International Congress on Obesity (ICO) were finalized in the early 1980s, with 
by-laws and an institutional structure finalized by the 1986 ICO meeting in Israel 
(World Obesity, 2015).  Though the journal and conferences had a small 
following, often attracting a few hundred scientists at maximum, early 
researchers were a close-knit group of junior researchers and often held 
impromptu dinner symposia to discuss current research and their visions for the 
field (Bray 2015; interview data). 
 Whereas in the 1970s and 1980s scientists focused on institutionalizing 
obesity research as a scientific field, by the 1990s scientists focused on gaining 
public attention and securing institutional interest and funding. In the early 
1990s, Drs. Richard Atkinson and Judith Stern formed the American Obesity 
Association (AOA), which was the first lay advocacy organization for obesity.  
They recognized a need for not only scientific interest—where NAASO primarily 
placed focus—but also public interest in the effort to legitimize the field. When 
the AOA formed, its founders were mocked within the scientific community. As 
obesity research continued to fight for legitimacy as a scientific field, members of 
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NAASO and leading obesity researchers questioned the objectives of the AOA, 
which specifically targeted the US Congress. Leaders of the AOA urged for 
public engagement similar to that of other “lay advocacy” organizations. As one 
prominent member of the AOA said in an interview, 
We had just seen AIDS totally change. This was a disease, when it was 
first identified, that was considered the disease of homosexuals and drug 
addicts. Both of those groups were highly stigmatized—they were way 
down on the list. Ten thousand people with AIDS marched on congress 
and within two years AIDS was given more research funding than any 
other disease at the NIH in research dollars. […] We needed a lay 
advocacy group, because many other groups—the American Heart 
Association, the Diabetes Association, Cystic Fibrosis—the list goes on 
and on, they had lay advocacy groups that are very powerful and get 
congress to provide research funding.  
 
Though they never had more than five hundred members, the AOA was 
incredibly effective in removing insurance obstacles for medicalizing obesity. 
Members of the scientific community were uncomfortable with having a 
secondary organization, in part because it competed for research funding and 
media attention, but also because it made the emerging field appear divided as a 
relatively small group of experts had established two organizations with slightly 
different goals and public engagement (interview data).  And in fact, in terms of 
attracting media attention, securing funding for research, and framing obesity as 
a disease to fuel epidemic rhetoric, AOA was a far more successful organization 
than was NAASO; in just one decade the AOA released comprehensive 
guidelines for the treatment of obesity, lobbied for reimbursement changes under 
private insurance and Medicare and Medicaid, and ensured the inclusion of 
obesity in the 2000 publication of Healthy People 2010 (Boero 2013; interview 
data). As AOA became more successful, NAASO realized that the public 
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engagement was crucial to the field and asked AOA to merge. In 2006, the two 
organizations merged and an award was created in honor of Drs. Richard 
Atkinson and Judith Stern, who had founded the AOA (ObesityWeek, 2014). 
 In a sense, efforts of the 1970s and 80s were less about getting the public to 
care about obesity and more about scientific establishment. Once the scientific 
commitment was there, advancements in the 1990s focused on public awareness 
and advocating for funding and insurance reimbursements. In interviews with 
senior obesity researchers, they reflect fondly on the scientific community that 
emerged during the 1970s and 1980s. Because the scientific community struggled 
to gain legitimacy with other scientific fields, strong emphasis was placed on 
generating solid, credible scientific knowledge. In one interview, a biostatistician 
lamented the loss of the model of mentorship that was foundational to early 
years of obesity research. Junior scientists were mentored and encouraged to 
learn, in depth, about the various aspects of obesity and metabolic science 
(interview data). Similarly, a researcher who trained under Dr. George Bray 
mentioned the incredible pressure for obesity researchers to produce credible 
scientific knowledge in order to justify their field as it was not highly regarded—
and perhaps still is not—by the larger scientific community.  
I went on an interview with [Bray] and at the end of the day he said to me, 
“alright, I’m willing to take you on as a fellow here but there is something 
you should know. There is a great deal of discrimination against obesity. If 
you go into the field of obesity research, you will have trouble getting 
grants, you will have difficulty getting research published, and you will 
suffer discrimination from your peers.” I personally have been looked in 
the eye by colleagues who said “obesity is not a subject of serious scientific 
inquiry.” Things are changing now, but the impression of academics in 
medical school and of most physicians then was that obesity docs were a 
bunch of slime-bags that just took advantage of people.  
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The fight for legitimacy as a scientific field contributed to formation the 
rhetorical strategy of complexity. Obesity researchers involved in internal 
medicine and pharmaceutical development rely on this frame and on distancing 
themselves from fad diet drug development and the weight loss industry. When 
I asked one clinical researcher what some of her biggest frustrations throughout 
her career had been, she pointed to this problem as well. 
My biggest frustration hands down is fraudulent weight loss claims. You’ll 
be watching TV and these advertisements are just ridiculous. These people 
and companies take advantage of people in our society who are 
desperately seeking to lose weight. The authorities are finally starting to 
clamp down on it and I actually wrote one of investigators a thank you 
note. But it’s a big problem for [the scientific community] because these 
untested, fraudulent claims get so much attention and press when there are 
valid approaches that don’t.   
 
As AOA advocated for more attention, funding, and an expansion of obesity 
research, more researchers and more disciplines became involved with obesity 
research. But what accompanied this, alongside opportunity for researchers, was 
the opening of a market for unproven obesity cures and weight loss intervention 
and foods as the above quote alludes to. In a caveat emptor consumption 
environment with relaxed regulatory standards for product marketing, this is a 
dangerous side effect of the obesity epidemic’s media success.  
The success of the 1990s was fruitful for all camps of obesity researchers. 
While public health researchers were present at the FICs in the 1970s, obesity 
was not considered a significant public health problem as it came to be in the 
1990s when rhetoric of the “obesity epidemic” flourished. With the advocacy of 
the 1990s, public health researchers seized an opportunity to expand 
involvement in obesity research and became crucial in the framing of the 
   
 
 
 
28 
“obesity epidemic.” For example, public health experts were enrolled in the 
production of documentary films to engage with lies and tactics of Big Food. 
Likewise, as the disease model of obesity gained traction in the 1990s, physicians 
and related industries pursued surgical options for obesity treatment and 
developed pharmaceutical drugs to treat obesity. The medicalization of obesity 
helped legitimate such interventions.  
 With the increase in funding of obesity research and the social 
construction of obesity as a major social problem, the number of people and 
disciplines participating in obesity science increased. Starting with a few 
hundred individuals at the FICs in the 1970s, there were over five thousand 
participants at ObesityWeek 2014. ObesityWeek is just one of several 
international obesity conferences held annually, along with national and regional 
conferences all over the world.  
 The field has been successful at getting scientists to identify as obesity 
researchers, obesity specialists, or as a member of “field X” who researches 
obesity (interview data). Although they may not agree about how obesity should 
be treated or its causal factors, as this chapter later explores, they readily agree 
that obesity is a health problem that must be taken seriously.  
2.3 Complexity and Multidisciplinarity as Rhetorical Strategies 
 
There is seldom an appreciation for the complexity of the obese condition in the 
media. As social scientists have argued, media framings of obesity largely blame 
the individual’s lack of will and lifestyle choice (Jutel, 2006; Saguy, 2013; Saguy & 
Riley, 2005; Saguy & Gruys, 2010). Under this popular framing, interventions 
require the obese individual to take responsibility for his or her health by 
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following expert guidelines for exercise and diet. Yet the field of obesity research 
has shown that there are other mechanisms that are equally, if not more, 
important than an individual’s behaviors. These mechanisms include genetic 
predisposition, metabolic function, neurological sensors, and epigenetic factors. 
The medicalization of obesity over the past forty plus years has been grounded 
in research of these factors—often claiming to reduce the obese stigma by 
removing blame from the individual though this is largely speculation. 
 In the excerpt that opens this chapter, Ethan A. Sims (1916-2010), an 
endocrinologist known for his work on experimental weight gain and for coining 
the term “diabesity,” called his fellow researchers’ attention to their misdirected 
adherence to a simplistic understanding of obesity. That only self-indulgence 
and overeating resulted in obesity, he and colleagues argued, could not explain 
all cases of obesity. Sims’ own work argued for a genetic predisposition for 
weight gain (cf. Sims, 1967; Sims, 1971). In the 1977 FIC conference proceedings, 
Sims and colleagues warned that this assumption would lead to “bad” science, 
restrict possibilities for treatment, and direct public attention and research 
funding toward behavioral modification models rather than disease models. 
Even then, researchers realized that obesity’s identity as a complex entity was 
important for more than just alleviating fat stigma,3 it had the potential to carve 
out a rich research enterprise.  
At the first Fogarty International Center Conference on Obesity in 1973, 
conference organizers and participants were housed in a variety of disciplines, 
                                            
3  In advocating for disease status, obesity researchers argue that labeling obesity as a disease 
will reduce social stigma because it will dislodge the commonly held position that “equates 
obesity poor character, lack of self-control, laziness, and gluttony (Allison et al. 2008). 
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including nutrition and dietary sciences, psychology, internal medicine, 
pediatrics, biochemistry, and epidemiology (Bray, 1979). Since then, its 
complexity has been used strategically to promote the funding of multiple fields 
for research into obesity’s causes, prevention strategies, and treatments. 
Obesity’s formation as a multidisciplinary knowledge field enables the framing 
of obesity as a complex condition—one that requires multiple disciplines and 
forms of expertise to understand cause and treatment and establishes obesity as a 
worthy field of scientific inquiry. Establishing this understanding required the 
field to dislodge a simplistic, age-old view of obesity that defined obesity as 
resulting from overeating and physical inactivity (Rowe, 1928; Newburgh & 
Johnston, 1929). Thus textbooks, health authority reports, and research papers 
emphasize its complex and multifactorial nature. As shown in the excerpts 
below, this has not faded with time but continues to more directly carve out 
opportunities for specific disciplines.  
Obesity is a complex and multifaceted chronic disease that develops from 
an interaction of genotype and the environment. Our understanding of 
how and why obesity develops is incomplete, but involves the integration 
of social, behavioral, cultural, physiological, metabolic, and genetic 
factors.  
– NIH Clinical Guidelines on the Identification, Evaluation, and 
Treatment of Overweight and Obesity in Adults, 1998 
 
Overweight and obesity are caused by many factors. For each individual, 
body weight is determined by a combination of genetic, metabolic, 
behavioral, environmental, cultural, and socioeconomic influences. 
Behavioral and environmental factors are large contributors to overweight 
and obesity and provide the greatest opportunity for actions and 
interventions designed for prevention and treatment  
– Office of the Surgeon General 2001  
 
Obesity is a complex medical problem. Health care professionals are no 
longer preaching a single approach to losing weight. It has become clear 
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that treatment must integrate physical activity, nutrition, psychology, and 
medicine. 
– Obesity: Etiology, Assessment, Treatment, and Prevention, 2003 
 
 
Obesity is a complex condition with many causal contributors, including 
many factors that are largely beyond individuals’ control.  
– Allison et al., 2008 
 
 
“[…] the many ways in which growing prevalence of obesity is a highly 
complex phenomenon, requiring multifaceted research in a wide variety 
of disciplines. Obesity research is conducted at a number of levels, 
focusing on molecules, cells, tissues, organs, systems, and behaviors 
throughout the lifecycle at the individual level as well as the interplay of 
factors and dynamics that prevail in families and communities which are 
influenced by social, economic and political realities prevailing in the US 
in the 21st century and the developing countries around the world  
– Textbook of Obesity: Biological, Psychological, and Cultural Influences, 2012 
 
Using complexity as a descriptor is a strategic framing as it both expands the 
fields overarching territory as well as the disciplines of actors (scientists) who 
can claim a stake in it.  
By the 2000s the number of fields expanded to include neurology and 
behavioral economics, bolstered the involvement of public health researchers, 
and enabled the creation of new fields of expertise such as bariatric surgery. 
Although usage of “epidemic” has been used by obesity researchers since at least 
the 1970s and can be found throughout the conference proceedings from the 1977 
FIC, it was not widely used in the media until the late 1990s, following the NIH 
clinical guidelines produced in 1998 (Saguy, 2012). The successful framing of the 
“obesity epidemic” that concretized by the mid-1990s provided added incentive 
for researchers of various fields to create links between obesity and their work, 
thus allowing their fields to claim expertise in regards to obesity. 
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Saguy (2013) traces the increased use of epidemic terminology in media 
articles between 1980 and 2000. Both she and Oliver (2006) contend that national 
maps produced by the CDC contributed to the uptake and proliferation of this 
terminology. Considerable lobbying on behalf of the AOA, in conjunction with 
the publication of the CDC obesity trend maps that showed alarming rates of 
increased obesity prevalence, and combined with increased interest within the 
scientific community, language of the obesity epidemic was concretized by 1995. 
The language of the epidemic symbolized prosperity for obesity researchers, in 
particular it increased funding opportunities and media attention. As the 
president of the American Dietetics Association wrote in 1998, for example, “the 
obesity epidemic offers us a golden opportunity to cement our status as the 
public’s best source of information and care for people who are overweight” 
(Coulston, 1998, p.1). Such a move highlights dieticians’ attempt to get a slice of 
the obesity pie.  
  Certainly no camp of obesity researchers claims to hold the key that will 
solve obesity. Instead, most researchers agree that such a complex problem 
requires a multifaceted approach. For example, one clinical psychologist I 
interviewed believed that while the causes of obesity were multifaceted and that 
it was unlikely possible to know the exact cause of obesity in a given individual, 
behavioral intervention could help to manage obesity. Conversely, internists I 
interviewed agreed about the multifaceted nature of causal mechanisms of 
obesity, but simultaneously contended that behavioral interventions not only 
prove ineffective on many obese populations, but that further studies in these 
areas should not be funded. These viewpoints are not incompatible, though, 
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because if there are more factors to consider, then justification exists for more 
research to be done and more funding to be procured. Recognizing obesity as a 
complex condition then, is critical for sustaining the research enterprise.  
If implemented, a multidisciplinary approach could have advantages such as 
the potential for solutions to incorporate multiple aspects of the problem (i.e. not 
simply treating obesity through pharmacotherapies, or to reengineer 
environments to facilitate healthy behaviors) and the ability for researchers’ 
understanding of obesity to be enhanced by multidisciplinary collaboration. 
However, for obesity research, this is rarely the case. Though the rhetorical 
strategy of complexity has been crucial to the expansion and sustainability of the 
field, the next section details how its multidisciplinary composition creates 
conflict among researchers in the field. Obesity has attracted researchers from 
fields that ascribe different understandings of the obese condition and how to 
best manage it. As the research field has matured, these distinctions have 
concretized into camps of researchers who adhere to different models of obesity. 
2.4 The Challenges of a Multidisciplinary Knowledge Field 
 
Current rhetoric emphasizes the value of multidisciplinarity as an approach to 
solving obesity. Yet the promise of multidisciplinarity is in practice far more 
complicated than the rhetoric or ideal suggests. In fieldwork and interviews, it 
was clear that there is distance and/or conflict between the various disciplines 
involved in obesity science. Although many disciplines constitute “obesity 
science,” for example, these fields often do not interact with each other. During 
my participant observation at ObesityWeek 2014, this trend was evident. Though 
over five thousand experts attend this conference from across the world, once 
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together they are segregated into tracks: metabolism and integrative physiology, 
neuroscience, intervention and clinical studies, population health, clinical and 
professional practice, and policy. Six silos form around the various tracks, and 
participants attend sessions within their track of expertise.  Not only does the 
specialization result in diminished conversation across the various tracks, but it 
also results in knowledge gaps between fields.   
When differences between disciplinary approaches and findings are 
acknowledged, they are regarded negatively. Researchers treat scholars from 
other disciplines as if they are ignorant, ill-advised, or just plain wrong. Some, as 
the biostatistician articulates in the excerpt below, believe this misinformation 
produced within the scientific community is responsible for miscommunication 
between science and the public. 
Miscommunication does reflect problems with the way we train people 
and the lack of bringing people up in a system of really being obesity 
scientists. It becomes this notion, “oh as long as I understand a little bit of 
public health, or nutrition, I’m good to go. I don’t need any more rigorous 
training than that.” I think that’s part of the problem and it’s something 
we really need to address. 
 
In comparing obesity to other disciplines, this researcher’s narrative exemplified 
one of the challenges of a multidisciplinary field.  
There’s a difference between obesity and everything else on that list 
[climate change, nanoparticles, and evolution]. Everything else on that list, 
for the most part the scientific community is unified, and the 
misinformation comes from outside the scientific community. So there is 
no—virtually no—credible person within the scientific community that 
thinks that, you know, evolution is not real, that species don’t evolve, that 
humans didn’t evolve from other species. It’s virtually unified. The 
dissent comes from outside the community. Obesity is different. With 
obesity a lot of the nonsense comes from within the scientific community. 
Or well, I should say within the “academic community.” I’m not sure I 
would call all those people scientists. It’s unintentional. Researchers make 
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silly mistakes; public health researchers rush in armed with the 
assumption that we know what’s going on with obesity. How much 
physiology do you need to know, if you assume [the cause of obesity] is 
behavioral?  
 
While this researcher’s critique of public health’s approach to obesity may be 
influenced by his own disciplinary perspective and funding conflict of interests, 
his remark about dissent within the scientific community is important. Another 
clinical researcher of internal medicine articulated, 
 
I think it will be a total dead end if we continue down the behavioral path. 
Unfortunately, more than half the people are behavioralists.  And if you’re 
a behavioralist, you certainly don’t want to hear anything about obesity as 
a disease.  
 
Researchers who advocate for the disease model of obesity also often point to the 
failed attempts of public health reform to change the food environment to 
support their argument that research funding should be channeled toward their 
respective disciplines. While it is unclear whether researchers consider the 
conflicting views on obesity as incompatible, when pressed in interviews the 
researchers I spoke with rarely used such stark language. Instead, they preferred 
to point out the priorities of other researchers as misguided, especially in 
comparison to the value of their own research. As a clinical researcher involved 
with the development of several anti-obesity drugs reasoned: 
I’m still distressed at the leaders in NYC who created a huge expense by 
mandating calorie labeling. They had no evidence at all that calorie 
labeling would do any good [to reduce obesity rates]. And yet they 
required all of the change. They didn’t require any of the [sic] fancy 
restaurants to put calories on their menus, but fast and cheap food 
restaurants had to do it. Then when it was assessed afterward, researchers 
showed that there was no difference and a few that showed that 
particularly young men, would buy the highest calorie things. These 
people actually thought they were doing something good, but in effect did 
little. 
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Obesity researchers belong to several disciplines and hallmark multidisciplinary 
approaches to preventing, treating, and reversing obesity. Yet they critique one 
another openly. All three researchers quoted above, and many researchers who 
advocate for biomedical approaches, namely bariatric surgery and 
pharmacotherapies, receive funding from either Big Pharma or from Big Food. 
Yet the varied approaches often stand in contrast to one another. The 
behavioralists alluded to above usually refer to the public health and psychology 
researchers, the former of which seek to modify the food environment and built 
environment; the latter to modify behavioral and design cognitive interventions.  
Though they too benefit from the increased attention and funding directed 
toward obesity, the public health researchers and psychologists I interviewed 
also viewed the biomedical approach to obesity with skepticism. They argue that 
disease status affords much for those working in internal medicine and 
pharmacotherapies, it offers very little in terms of combating obesity and 
changing the environments that produce and sustain weight gain. They warn 
about the dangers of the biomedical approach, particularly for populations that 
are disproportionately obese and often also disproportionately impoverished. 
Public health researchers seek to affect environmental change through changing 
food and built environments. But they are often up against a wall; though public 
health is allocated a significant portion of NIH funding, minor changes to the 
environment fly in the face of a multi-billion dollar food industry and a 
government that favors Big Food.  
Bariatric surgery, treatment failure, set point, and treatments all point to 
one thing: prevention. We have to stop thinking in terms of just letting 
freedom, and free will, and free market do their thing because what 
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they’re doing is making us fat. We have to think on an individual level, a 
parental level, and a societal level. We need to make prevention of 
unnecessary weight gain the priority. 
 
Psychology and public health research on obesity often intersects, and many 
documentary films on obesity feature such researchers working side by side. 
Where psychologists emphasize training individuals to change behaviors within 
existing environments, public health researchers emphasize changing the food 
and built environment. Their work intersects because they realize that Big Food 
is a “David and Goliath” battle (interview data), and that for individuals to gain 
control over what is possible, they must adjust to the environment in which they 
live along with individual behaviors.   
The HBO and Institutes of Medicine (IOM) series The Weight of the Nation 
(2012), which will be discussed again in the following chapter, exemplifies this 
tactic. In the four part series, changes in food production and food marketing, 
coupled with decreased physical activity are confirmed, by public health, 
nutrition, and policy experts to be the culprits of the obesity epidemic. Though it 
aired three years ago, Weight of the Nation is still accessible, for free, from HBO’s 
website to promote education about the obesity epidemic. This film, and a 
number of similar ones including Fed Up (2014), Fat Sick and Nearly Dead (2010), 
Food, Inc. (2008), and A Place at the Table (2012), critique the government 
institutions that have placed corporate success over the health priorities of the 
nation.  They seek to educate their audience about the “behind the scenes” 
workings of Big Food, Pharma, and Government while arming their viewers 
with the tools to make better food choices in a “toxic” (Brownell & Horgen, 2004) 
environment. 
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On one hand, such films and research do create awareness about the 
unethical practices that have been come business as usual in some of the nation’s 
most powerful institutions. But while their attempts are admirable, they fail to 
effect the large-scale societal change that is needed and still place the 
responsibility to understand the motives of the food industry and the meaning of 
nutrition labeling and food packaging on the consumer.  
 Though they position themselves opposite the obesity researchers whom 
they critique, I’d like to suggest that the camps of obesity researchers are less 
different than they believe. That is, both public health researchers and 
biomedicine researchers both seem to accept that real social change—that is, 
redesigning the built environment and the food environments—is impossible. 
Thus they redirect their attention to finding solutions that are coherent within 
their discipline specific domains and offer critique from their dual vantage point 
as people who appear genuinely concerned about obesity’s health implications 
and as stakeholders concerned with securing their positions. 
2.5 Conclusion 
This chapter demonstrated how physicians led the institutionalization of 
scientific obesity research as a field in the 1970s and 1980s. Until the late 1960s 
and early 1970s, researchers studying obesity were somewhat isolated until the 
Fogarty International Center hosted two obesity-focused conferences in the 
1970s. As Bray wrote in a 2015 memoir, obesity was considered a major public 
health problem prior to the 1970s, but primarily by those in the scientific 
community. Recognizing the economic realities their profession faced, obesity 
researchers launched an effort to more fully establish and expand their enterprise 
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(Bray, 2015). The FICs were the first steps in connecting researchers from a 
variety of disciplines and setting an agenda to develop the research enterprise. 
Momentum continued throughout the 1970s and 80s as researchers established 
obesity-centric journals and held scientific conferences. Finally, lobbying by the 
AOA and NAASO in the 1990s helped transform obesity into a social problem 
and elevate it to the forefront of the public health agenda.   
To establish obesity research as a legitimate field, members of the field 
promote the framing of obesity as a complex condition requiring 
multidisciplinary approaches.  This framing sees to 1) dislodge the simplistic, 
stigmatizing perspective of obesity, and 2) support the biomedicalization of 
obesity. As expected, this rhetorical strategy does not translate to practices of the 
field. The chapter also explains some of the problems multidisciplinary fields 
face, namely the conflict between researchers of different disciplines.  
Obesity research spans fields from internal medicine to psychology to 
neuroscience. Not only are disciplinary traditions followed (and their core 
assumptions), but research findings often point toward different intervention 
strategies. At times, studies may seem to contradict one another—perhaps 
advocating for opposing but not incompatible approaches. So while internal 
conflict surrounding research agendas is very clear among members of the field, 
these differences operate within bounds; this diversity is not only accepted, it is 
strategic. For instance, debates often erupt regarding whether a behavioral or 
disease model is a preferable model for conceptualizing and communicating 
obesity. While these models suggest different causality theories and treatment 
plans, they not question whether obesity is a problematic health condition. That 
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is, disciplinary distinctions lead to disagreement about how to treat obesity, not 
whether we should treat obesity.  
Disciplinary conflict is perhaps uninteresting in and of itself. However, 
attending to this field’s internal conflict is analytically rich because it highlights 
how scientific fields are social entities. It illuminates a provocative insight into 
scientific field formation to question how researchers share some rules of 
understanding but fundamentally disagree about others. Though obesity 
research has gained momentum over the past sixty years and researchers from 
various disciplines work side by side, the scientific community remains divided 
about the core understandings about how to interpret the results of studies, 
where funds should be channeled, and in what direction the field should move 
forward. So while researchers promote a multidisciplinary approach to 
understanding and treating obesity, the conflicts highlight the limits of its 
rhetorical strategy. In the next chapter, I take up the history and use of BMI in 
obesity science. BMI has been a crucial technology of stabilization, and its use 
helped the obesity scientific enterprise to form and expand.  
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Chapter 3: Standardizing Adiposity, Categorizing Bodies: BMI as a 
Technology of Calibration 
  
In the opening minutes of the widely televised Weight of the Nation, the National 
Institutes of Medicine and HBO provide a thirty-second history of BMI’s 
inclusion in obesity research.4 A cartoon version of Adolphe Quetelet appears on 
the screen and the audience is carried through a short and sweet narrative 
explaining how BMI became obesity’s metric. The story begins with Adolphe 
Quetelet who developed the “average man construct.” The physical part of the 
average man construct was then picked up in the 1940s by Metropolitan Life 
Insurance statistician, Louis Dublin. He analyzed population data using 
Quetelet’s equation (W/H2) against mortality rates and observed a “J shaped” or 
“U shaped” curve. As far as Weight of the Nation is concerned, this was a happy 
coincidence and the rest is history. And in fact, no clinicians or researchers I 
interviewed for this research cared to know more than that.5 The narrative that 
has been promoted, and the history that has been forgotten, contribute to the 
staying power of BMI as an indicator of obesity and the social framing of obesity.  
The analysis of historical documents, interview data, and participant 
observation conducted during ObesityWeek 2014 for this chapter paints a far 
more complex history of BMI’s inclusion in obesity research. Rather than 
flattening and forgetting its history, this chapter articulates the multiplicity of 
meanings BMI carries in scientific obesity research and the outlets through which 
                                            
 4 The Weight of the Nation was a four part series that aired in 2012. HBO and the Institutes of 
Medicine (IOM) partnered to produce the project in association with the Centers for Disease 
Control and Prevention (CDC), the NIH, the Michael & Susan Dell Foundation, and Kaiser 
Permanente. The series was comprised of four documentary films: Consequences, Choices, 
Children in Crisis, and Challenges.  
5 Clinicians I interviewed were not concerned with why the indicator was chosen or how it was 
developed. They recognize it for its practical uses and choose not to use it as they see fit.  
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such research is disseminated to the public. This chapter dives into the scientific 
research to uncover how BMI accrues meaning in obesity research and the roles 
it performs for researchers’ practice to bring two key arguments forward. First, I 
argue that BMI serves as “the right tool” for obesity researchers to stabilize the 
fields’ various disciplines, standardize research, and to efficiently communicate 
obesity’s risks and health complications to government agencies, potential 
funders, and to the public. In effect, I argue BMI became the right tool not 
because of its precision or accuracy, but rather because of its flexibility that 
enables it to contribute in a cohesive manner in a particular context. When BMI is 
an accurate and effective measurement, it provides the credibility researchers 
need. But when it fails to correctly predict health complications, researchers 
remind their audience that BMI is a crude, flawed measure. To demonstrate this, 
I draw on two cases in which research studies questioned the prevailing 
assumption that higher BMI is detrimental to health. Analysis of these cases lead 
to my second argument, in which I contend that the meta-level, the level of 
dominant discourse, problematic framing of fatness hinders researchers abilities 
to decouple weight and health. That is, the belief that ‘big is bad’ apprehends 
researchers from asking questions about the social and environmental factors 
that lead to health disparities.  
3.1 BMI: the Right Tool for the Job? 
 
Since the mid-twentieth century, obesity research, the weight loss industry, and 
the fitness industry have prospered on the stigmatization and cultural focus on 
obesity (Dworkin & Wachs, 2009; Saguy & Riley, 2005). Annually more than $800 
million publicly funded dollars are spent on obesity research examining causes, 
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treatment, and prevention (NIH, 2015). Yet rarely do researchers, public health 
practitioners, and health policy makers reflect on why we define obesity the way 
we do. As mentioned in the introduction, BMI thresholds define obesity globally 
(AMA, 2013). When asked, few obesity researchers I interviewed are familiar 
with BMI’s history and development as a health indicator. Generally, they do not 
believe that its historical development has implications for their practice. Social 
scientists tend to feel differently, noting that BMI’s history has implications for 
its current use (Davis, 2006; Boero, 2013; Oliver 2006).  
BMI has roots in 19th century Belgium, as The Weight of the Nation narrated. 
Adolphe Quetelet, a Belgian statistician who served as the Director of the 
Brussels Observatory and on the Directory of the Royal Academy of Brussels, 
Berlin, and Turin (among many other positions), developed the measurement as 
part of a project to describe the physical qualities of man. In one memoire, he 
presented the development of this measure. His research agenda sought to 
accurately describe the physical development—height (size) and weight—of 
persons of the era as they aged, from birth to death (Quetelet, 1835).6 He observed 
that the ‘law of error,’ which was used by astronomers to locate stars by plotting 
all sightings and then averaging the errors, could be applied to the distribution of 
human features (Davis, 2006; Oliver, 2006). Quetelet constructed the concept of 
the ‘average man,’ which was both a physical and moral averaged construction 
(Davis, 2006, p. 4). In doing so, he created a definition of normal that functioned 
as a moral imperative, dividing and classifying life (Davis, 2006).  
                                            
 6 This memoire is published in French as Sur l'homme et le développement de ses facultés ou 
essai de physique sociale (Vol. 1). Some of this work was later printed in English (1842). 
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The physical component of this measure, W/H2, was used in 
anthropometric research throughout the late 19th century and into the 20th. It went 
by various names, including ‘Quetelet’s Index,’ ‘index of weight relative to 
stature,’ ‘index of build, ‘weight-height index.’ Louis Dublin, a statistician at 
Metropolitan Life Insurance Company (MetLife), picked up Quetelet’s 
methodology in the 1940s. The company was interested in developing tools that 
could more accurately predict mortality, enabling MetLife to make smarter 
insurance decisions (Oliver, 2006). In his statistical analysis, Dublin found that 
people closer to the average weight for their age lived longer. Dublin developed 
ranges for each height that would be deemed “normal weights” and developed 
the MetLife weight tables. Doctors, epidemiologists, and the federal government 
adopted and promoted MetLife tables to analyze population health beginning in 
the 1940s.  
That said, it is important to note that BMI was developed as a descriptive, 
physical average; it was not developed to be a health indicator. Until Dublin’s 
innovation, BMI had not been intended to predict health states. Popularized, 
BMI’s predictive power took on new meaning in practice: people came to 
understand fat as causing disease and death (Oliver, 2006, 16-19). Political 
scientist Eric Oliver concludes, “[u]ltimately, the most influential factor in 
determining what Americans considered to be overweight was not based on 
criteria of health but criteria of profit and measurement within the insurance 
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industry” (p. 19). Thus, BMI classifications and weight-risk tables were not —and 
are not—based in health science.7   
3.2 Stabilizing the Field: BMI as a Technology of Standardization 
 
This chapter extends STS scholarship on technology of standardization by 
investigating how BMI operates in obesity research, what meanings it accrues, 
and how its deployment shapes research agendas. Investigating measurement in 
obesity research can serve as a window to understanding how health categories 
are constructed and normal and deviant bodies are demarcated, along with the 
ways in which standardization can stabilize a highly diversified knowledge field 
and create shared rules of understanding. 
To understand the stabilizing function BMI serves in obesity research, this 
section builds on Chapter 2’s account of the establishment and growth of the 
field of obesity researcher to tease apart the inclusion of BMI. This section 
identifies several important junctures in which BMI is affirmed as a useful tool 
for obesity research in order to explain its role as a stabilization tool.  
 In 1972, epidemiologist Ancel Keys and colleagues proposed to term the 
relative weight index of W/H2 the “body mass index” (Keys et al., 1972, p. 331). 
Their paper compared BMI against other relative measures of weight, including 
the ponderal index and weight-height ratio. Finding that BMI had stronger 
correlation to measures of body fatness and weakest correlation to height 
variation, they concluded that “based on these grounds as well as on the 
simplicity of the calculation, and in contract to percentage of average weight, 
                                            
 7 While Oliver does critique the rhetoric of the obesity epidemic, he also problematizes obesity.  
He concludes that obesity should not be treated as a problem-in-itself, but rather as a symptom of 
lifestyle changes over the past thirty-five years (Oliver, 2006). 
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applicability to all populations at all times,” (Keys et al., 1972, p. 341) BMI was 
the preferred index. In a second review of anthropometric measurements in 1977, 
Womersley and Dumin concluded that skinfold measurements were the “most 
appropriate simple indices,” but that where skinfold measurements were not 
possible, W/H2 was the next best choice because of its computational ease. Since 
then, it has been accepted as the standard for human classification as under, 
normal weight, overweight, and obese.  
Prior to the FICs, a range of measurements such as skinfold measurement 
of body composition, waist circumference, bioelectric impedance, underwater 
weighing, and air-displacement plethysmography were regularly used in 
research studies either instead of or along with BMI to categorize bodies and 
describe study conclusions (Bray, 1979, p. 25-32). These measurement techniques 
offer varied levels of precision, time investment, and required various forms of 
expertise. Though arguably BMI offers the least precision which could render it 
the least valuable, it also requires no expertise or financial cost. When called 
under fire for its inaccuracy, these qualities seem to provide the necessary usage 
for its continued usage. Today, BMI is fully routinized in health care; it is part of 
a patient’s health record and is calculated by computer systems when nurses and 
hospital personnel enter a patient’s weight and height (interview data).  
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At the first FIC in 1973, the expert 
community recommended that clinicians rely on 
the Fogarty Center Tables (see Figure 1 left), 
which was an adaptation of the Metropolitan 
Life Insurance Table (Bray, 1979). Note that 
these tables do use BMI in their calculation, but 
take a different form in that they provide an 
acceptable weight range without assigning a 
BMI value to an individual. At the 1977 FIC, 
recommendations shifted, calling investigators 
and clinicians to consider using BMI as a 
method of relating variations in weight to height 
and consider more specific means of assessing 
body fat and its distribution, particularly when 
such data may affect interpretation of the results 
(Bray, 1979, p. 5). 
 Within the broader scientific community 
of obesity researchers, BMI’s first affirmation as 
the indicator of choice for categorizing 
overweight and obese occurred during the 
second Fogarty International Conferences (FIC) 
conference held in the 1977. As detailed in 
Chapter 2, the two Fogarty International 
Fogarty Center Tables were recommended to 
clinical researchers and physicians following the 
1973 Fogarty International Conference. While 
these values were calculated using BMI, 
information is not conveyed by assigning a BMI 
value.  
Figure 1: Fogarty Center Height-Weight 
Tables 
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Conferences (FIC), held in the 1973 and 1977, set the stage for the scientific 
obesity research enterprise. These conferences were significant not only because 
they generated momentum within the research community, but also because 
important discussions were held about definitions and criteria, credible research 
practices, and guidance for setting research agendas/programs created the 
conditions needed for obesity science expansion (NIH, 1977). 
At the 1977 conference, experts addressed the shortcomings of BMI and 
encouraged researchers to improve the methodology to quantify body fat. Such 
shortcomings included its inability to assess the distribution and implications of 
body fat, its inability to predict health at an individual level, and its inability to 
account for frame size (Bray, 1979, p. 6).  Importantly, these same shortcomings 
are echoed nearly forty years later (CSAPH, 2012).  
While researchers acknowledged the limitations of BMI during the 
formation of the research enterprise, their priority was kick starting 
multidisciplinary research on obesity rather than perfecting this measurement 
tool. They understood that BMI as an imprecise measurement, but found it 
sufficient to categorize risky populations and screen patients for potential health 
risks. In their recommendation of BMI as the standard, Keys et al. (1972) write: 
In much of the literature, especially in discussions of clinical problems and 
in reports from the life insurance industry, relative weight is taken as a 
measure of obesity or fatness in spite of repeated demonstrations and 
warnings of the serious errors arising from that confusion. […] it is 
unlikely that any weight index [in the middle range of various weight 
indices] will provide an acceptable indication of adiposity or body fatness, 
though relationships became more apparent as the relative weight departs 
further from the population average (p. 331). 
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Similarly in the conference proceedings from the FIC 1977, Bray recommends: 
Investigators should consider using the body mass index as a method of 
relating variations in weight to height and consider more specific means 
when such data may affect interpretation of the results. 
 
Early scientists believed that obesity as a health problem existed even 
without BMI to measure it. They did not, therefore, need BMI to prove that 
obesity exists. Rather, they viewed BMI as an easily deployable technique that 
would enable physicians to identify obesity, compare studies and results, and 
assess next steps for patient care. 
At this juncture, BMI was 
understood as a measurement that 
could indicate whether a patient was 
at risk for certain health complications. 
While it was not conflated as a health 
indicator, it was used to determine an 
individual’s risk for other health 
conditions in clinical settings. BMI also 
provided calibration for categorizing 
bodies and though the definitions 
provided were still distinct from BMI 
measurement, those categories were 
overlapped onto the nomogram for 
BMI (Figure 2 left), corresponding to 
the acceptably range of weights 
BMI nomogram from Fogarty International 
Conference, 1977. Published in Bray (1979) Obesity 
in America.  
Figure 2: Body Mass Index (BMI) Nomogram 
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detailed in the MetLife tables. Finally, and perhaps most importantly, it provided 
an accepted and expert-endorsed scheme that could be used to design research 
studies and to define desirable outcomes.  
At the opening and closing of the 1980s, BMI was affirmed as an 
acceptable measure for obesity twice more. The first time was the inclusion of the 
categories overweight and obesity in the US Department of Health, Education, 
and Welfare8 1979 Healthy People Report. As Boero (2013) details, overweight 
and obesity are paid little attention in this publication. Obesity and overweight 
are mentioned and they are defined using BMI, but they were not elevated to the 
status of leading health indicators just yet. Again, the Department of Health and 
Human Services includes overweight and obesity in the Health People 2000 
Report, which was published in 1990, but without much attention. 
The AOA’s lobbying efforts, the release of the CDC maps on obesity, and 
a media explosion fueled BMI’s conflation as a health indicator during the 1990s.  
In 1998, overweight and obesity BMI thresholds were lowered by the NIH. The 
sex specifications were removed (recall Figure 2 had separate standards for 
males and females), frame size distinctions ignored, and the overweight category 
was lowered to 25.0 from previous standards of 27.8 for males and 27.0 for 
females. This collapsing has been widely critiqued, even by those within the 
scientific community (Boero, 2013; Guthman 2011; interview data; Kassirer & 
Angell, 1998; Squires, 1998). Following a trend in American medicine, the 
definition of normal has been increasingly narrowed, thus positioning more and 
                                            
8 In 1979, the Department of Education Organization Act was signed into law. The Act provided 
for the creation of the Department of Education. The US Department of Health, Education, and 
Welfare became the US Department of Health and Human Services officially on May 4, 1980 
(HHS.gov). 
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more people as diseased or abnormal (Greene, 2007; Clarke et al., 2003; Dumit, 
2012). This downward shift greatly increased the number of people whose 
weight became problematic; some estimates suggested that nearly thirty million 
people previously considered healthy were now labeled overweight (Squires, 
1998).  The lowering of BMI thresholds for overweight and obesity meant that 
more people could then be labeled as at risk and in need of interventions, 
opening up opportunities for pharmaceutical companies (interview data; 
Squires, 1998).  
In 2000, the publication of the DHHS Healthy People 2010 confirmed that 
obese and overweight, as defined by BMI, are health indicators. Finally in 2013, 
BMI was given the authority to label individuals diseased when the AMA 
Resolution 420 declared obesity as a “disease state with multiple 
pathophysiological aspects requiring a range of interventions to advance obesity 
treatment and intervention” (AMA, 2013, p. 2). The AMA was not alone when it 
took this controversial stance. When Resolution 420 passed in June 2013, the 
World Health Organization, the Food and Drug Administration, the National 
Institutes of Health, the American Association of Clinical Endocrinologists, and 
the Internal Revenue Service (for deduction purposes) had already recognized 
obesity as a disease (AMA, 2013). While clinical researchers contend that disease 
status matters little in practice, it showcases BMI’s role in obesity research.  
In each of these instances, the limitations of BMI are acknowledged, but 
despite such acknowledge BMI’s inclusion is still supported. Thus, I argue BMI 
performs a stable, organizational function for the field and it performs a 
productive role as obesity moves up in the spotlight. BMI is strategically used as 
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a measurement of standardization. It provides a metric from which statistics can 
be created to justify the increased attention being paid to obesity. Its use enables 
“obesity” to exist as a quantifiable, detectable abnormality. This move enables 
obesity research and the social framing of obesity as an abnormal, problematic 
health state in need of intervention to gain ground, money and attention.  
3.3 Meaning Making in Obesity Research 
 
The obesity scientists I interviewed (regardless of discipline) fully 
understood that BMI is not a predictor of individual health. When asked about 
BMI, many expressed grievances that so much media and public attention was 
directed to BMI’s flaws rather than on “good” research—though there was no 
consensus between fields on what was meant by good research. As mentioned in 
the last chapter, the concept of what is classified as good research among 
members of the field is contested. 
Nevertheless, researchers articulated how they use BMI in their clinical 
and research practices.  As one clinical researcher, an endocrinologist though 
trained as an oncologist, remarked: 
BMI is a screening tool; it is not a diagnostic tool. It’s the first step 
following which there is waist circumference and other risk factors, so 
what you’re really trying to identify is people who are at risk because of 
their body weight. I don’t get really hung up on this whole, “oh it’s not a 
disease because there are people with a BMI of 30 who are perfectly 
healthy” argument. Well, yeah, that’s true. But it doesn’t hang me up and 
let me tell you why: if you can pass the MCAT with a score to get into 
medical school, you should be able to tell that [BMI] is just a screening 
tool. Use it to then go further to identify people who are at risk for other 
health issues. Do we really need to put somebody in a special machine 
that costs $1,000 per test? No, we don’t need to do that. It [obesity] is a 
clinical diagnosis in which the first screening is BMI. 
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This researcher alluded to a favorite trope among both obesity researchers and 
the media: the desirable, heteronormative, athletically built man. When pointing 
to cases where BMI is useless, researchers and journalists call out body builders, 
football players, and the like as opposed to a bigger boned person. This is 
strategic imagery—though it defies BMI, it still portrays the image of “health” 
and the behaviors associated with it such as good nutrition and regular physical 
activity. When editorials or research studies that question the efficacy of weight 
loss or usefulness of BMI were released, researchers felt that it was detrimental to 
the field’s goals. 
In the CSAPH report, they write “a better indicator than BMI is needed” 
to determine whether obesity is a disease. And unfortunately, there is 
nothing better than BMI that can be used on a population level at this 
point [for economic and implementation purposes]. In the general 
population, BMI is a pretty good metric—it’s a pretty good proxy for total 
adiposity. 
 
The researcher above understood that BMI didn’t work at an individual level, 
but for those interested in population analyses, it gets the job done with little 
cost. Related, as the following quote demonstrates, researchers believe large-scale 
studies that question this generally agreed upon fact threaten the field’s stability 
and their ability to reach the public. 
  
When epidemiologists release studies showing that, across the population, 
weight loss is associated with mortality, it sets us back. Now I’m not 
criticizing them, I think it is important that [researchers] calls it like they 
see it. But they aren’t looking at intentional weight loss. And the hundreds 
of studies that have been done on intentional weight loss within obese 
populations show that even a 5-10% weight reduction can have 
tremendous benefits for the comorbidities that often accompany obesity. 
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At the same time they defended the usage of BMI in obesity research and its 
function in improving population health, the researchers I spoke with often 
alluded to not needing BMI. In most of their work the presented cases of obesity 
were clear—many clinical obesity researchers were working with obese patients 
with comorbidities who were seeking weight loss (interview data). Similarly, in 
commenting on recent work that promotes the usage of waist circumference as a 
better indicator for obesity, one researcher said: 
BMI is the best simple indicator that we have that can be used on a very 
broad scale. If a person already has obesity, then they will likely have a 
high waist circumference, so really waist circumference is only useful for a 
smaller subset of the population. 
 
It is crucial to note that the majority of these critiques of BMI are that they 
misdiagnose patients. But clinicians and population health researchers are less 
concerned about labeling someone “unhealthy” who is actually “healthy” and 
more concerned with not labeling someone who is not obese but is metabolically 
unhealthy, as healthy. I return to this discussion later in the chapter in the 
discussions of the obesity paradox and the metabolically healthy obese 
populations.   
 In the clinical setting, BMI holds much less power than it does in 
population studies. In a sense, then, the inclusion of BMI in official reports and 
authoritative declarations misdirects our attention. BMI is superficial in that it 
signifies the weight status of individuals, but it does not and cannot tell us about 
an individual’s health. Researchers readily admit this, but do not see it as an 
issue for the field, because of BMI’s utility to standardize research.  
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 The significance of its superficial or framing role should not be 
underestimated; while among clinical researchers BMI may not carry much 
meaning, when these studies are translated to the public, their interpretations 
enter a domain in which obesity and BMI go hand-in-hand and where obesity 
research, no matter how detached from BMI, is subject to this slippage.  
 For instance, scientists have recently been exploring linkages between 
cancer and obesity. A 2014 CNN article (Wilson, 2014) reported on a series of 
recent studies on obesity’s relationship with lung, pancreatic, and liver cancers. 
These studies explored the relationship between cancer development and chronic 
inflammation, fat tissue production of adipokines (which play a role in 
stimulation and inhibition of cell growth), and visualization issues caused by 
excess fat tissue. Yet the article provides a very simplistic overview of the highly 
technical reader, and ends with a bit of advice:  
Start reducing your risk now: stay active. Eat nutritious foods that are low 
in calories. Get seven to eight hours of sleep per night. Manage your stress 
levels. All of these behaviors will help you reach a healthy weight. 
 
The scientific work this article draws from points to the underlying mechanisms 
that result in obesity. Arguably, these studies could lead to the alterations of 
environments that pose such harm. In this way, they could support the initiatives 
of public health researchers that seek to modify built and food environments. 
And yet, they seem to end with the same solutions that emphasize personal 
responsibility and control over weight accumulation.  
 While most scientific research does not disrupt the guiding frame of the 
BMI paradigm, nor the cultural attitude that favors individual behavioral 
prescriptions, two areas of research present interesting controversy within the 
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field. As discussed in the next section, these findings more fully demonstrate 
obesity researchers’ framing power and deployment of BMI in obesity research. 
3.4 Problematic Science: Metabolically Healthy Obese and the Obesity 
Paradox 
 
Despite the rise of obesity enterprise and its assumption that obesity is a 
health problem, there have been research studies published by members of the 
scientific community that challenge the very framing of obesity as related to ill 
health or illness. These cases are analytically interesting because of the critique 
they have received within the scientific community and the controversies they 
have sparked. To illustrate this, I draw on recent provocative research studies 
that have the capacity to question whether obesity is a problem and if 
intervention is necessary. Put differently, they challenge the dominant belief that 
obesity is always problematic. Through analysis of these two examples, the 
metabolically health obese and the obesity paradox, I explore how controversy 
among researchers can show how dominant framings of obesity permeate 
researchers’ idealized objectivity. That is, the prevailing belief that obesity—as 
constructed by BMI—is always problematic for health influences obesity 
researchers to interpret findings in ways that do not shake the enterprise. These 
examples are analytically rich because they illuminate how meta-level framing 
encourages researchers to orient studies in specific directions while closing off 
other potential interpretations that would question the existing assumptions 
integral to research programs.  
 In recent years, obesity researchers, primarily situated in internal 
medicine, have characterized a subphenotype of the obese population, which has 
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come to be termed “metabolically healthy obese,” hereafter referred to as MHO. 
Studies show that MHO are healthy obese individuals, in that they are insulin 
sensitive and have lower liver fat content and intima media thickness of the 
carotid artery similar to their normal weight, healthy counterparts (Wildman & 
Rajpathak, 2008). Thus, MHO individuals are at low risk to develop metabolic 
and cardiovascular diseases. Metabolically, these individuals are more similar to 
“normal” weight individuals than to individuals closer to their BMI.  
 Recognition of the MHO population is problematic for the field of obesity 
research because this population threatens the field’s central tenet that the obese 
state is a dangerous health state. Research conclusions from these studies 
question the efficacy of interventions and whether, in an economic moment of 
ever increasing healthcare costs, these individuals should even be treating these 
populations. But other researchers disagree. They point to studies that have 
tracked MHO populations for over ten years. With aging, or, time, risk factors 
start to develop. According to these researchers, the MHO is a “temporary state” 
that should be intervened before the risk factors begin to develop. But, other long 
term studies are needed to see if this critique holds true.  
 Similar to the existence of MHO people, in 2002, cardiologist Luis Gruberg 
and colleagues observed better outcomes among coronary heart disease patients 
undergoing percutaneous coronary intervention that were overweight and obese 
(Gruberg, 2002). They called this an obesity paradox. Their findings sparked a 
controversy that continues thirteen years later. In a 2013 review article, 
endocrinologists Hainer and Aldhoon-Hainerova explored potential biological 
explanations that could explain the paradox. They conclude: 
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Despite the fact that obesity is recognized as a major risk factor in the 
development of cardiovascular diseases and diabetes, a higher BMI may 
be associated with lower mortality and a better outcome in chronic 
diseases and health circumstances. […] Nevertheless, the discussion over 
the obesity paradox cannot lead to an underestimation of obesity as a 
crucial risk factor for the development of cardiovascular and metabolic 
diseases that require[sic] comprehensive prevention and management 
strategies (Hainer & Hanerova 2013, p. S279-80). 
 
The authors remark that BMI is a “crude and flawed anthropometric biomarker” 
(ibid. S280), reminding their audience that other measures that affect a patients 
health risk and mortality, including fat mass/fat-free ratio, nutritional status, 
cardiorespiratory fitness, and body fat distribution, are more useful health 
measures. Supporting the claim that other health measures are better predictors 
of an individual’s health, Gonzalez et al. (2014) observed that the obesity paradox 
only existed when the measurement for obesity was BMI. In the study, when 
obesity was assessed using bioelectrical impedance analysis (instead of BMI) 
there was no indication of the obesity paradox (Gonzalez et al. 2014). 
 Within the scientific community, the MHO and obesity paradox do not 
challenge researchers’ understanding of obesity. Instead, researchers become 
defensive and use BMI’s limitations as a scapegoat and rely on explanations of 
aging, the wasting syndrome, and sarcopenia to explain why the both cases are 
often found in elderly populations.  If anything, these cases offer two important 
lessons to the scientific community. First, they highlight the potential limitations 
of BMI when predicting individual health outcomes and second, they support 
the idea that “miscommunications” originate within the scientific community 
(interview data).  That is, while MHO and the obesity paradox have been 
presented in the media as a shocking discovery that you can be large and fit 
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(here, fit signifying metabolic and cardiovascular health)9, rather than opening up 
conversations about weight discrimination against fat people, in particular fat 
women, face when seeking medical care (LeBesco, 2010; Throsby, 2007; Wann, 
2013). 
 Analyzing the scientific community’s response to research on MHO and 
the obesity paradox illuminate how the dominant social framing of obesity as a 
health problem influences their research.  A clear example of this occurred 
during a scientific session at ObesityWeek 2014, when prominent epidemiologist 
Dr. Mercedes Carnethon gave a key lecture on the obesity paradox. Discussing 
the implications for the public, Carnethon claimed that the public wanted to 
believe in an obesity paradox, that the media more heavily covers studies that 
were provocative (showing that the paradox exists), and that rising rates of 
obesity in the population have led toward normalizing obesity. Instead of 
engaging with the implications of the obesity paradox, she moved on to talk 
about the need for research into the metabolically obese normal weight as this 
population is at high risk and that perhaps we should discuss the obesity 
paradox as a BMI paradox instead, to highlight that the imprecision of BMI. 
Following the lecture, in response to clinical researcher’s remark that the obesity 
is never a healthy state, but that such individuals have other, perhaps genetic, 
factors that contribute to their healthy state, Carnethon said:  
I equally feel uncomfortable when I’m pressed to say that being obese and 
overweight is a better way to be, especially in the setting of chronic 
                                            
9 Following scientific articles released in major cardiology scientific journals (including the Journal 
of the American College of Cardiology), a number of media stories covered the obesity paradox. 
These articles still problematize fatness, particularly visceral fat. For example, one article 
concludes “[a] high BMI was associated with a 35 percent lower risk of death, but having a large 
waist circumference in addition to a high BMI nearly doubled the risk of dying (Harding, 2011).”  
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diseases because there are too many reasons that could explain why that’s 
the case that are real […]. It’s an uncomfortable proposition to say, ‘don’t 
lose weight, it’s dangerous. 
  
Recalling Fortun’s (2009) scale as a heuristic discussed in Chapter 1, we can use 
this example to illustrate how macro level forces permeate all the way to the 
micro and technological levels of organization. The obesity paradox findings of 
Gruberg (2002) and subsequent studies inspired other researchers to investigate 
the factors related to the obesity paradox. These studies seek to understand what 
the protective factors are that seem to prevent overweight and obese people from 
experiencing the negative health risks often associated with obesity. None of 
them have been conclusive and instead point to the importance of fat 
distribution, circumventing any critique of study design. Said differently, the 
macro framing of obesity leads scientists to specific research agendas, closing 
other possibilities. The obesity paradox and the MHO cases could have lead 
researchers to ask themselves whether they were looking at the wrong variable 
(obesity) and missing something else. Instead, it seemed impossible to think that 
obesity could not be a problem and researchers threw BMI under the bus once 
again. 
3.5 Conclusion 
 
This chapter details how and when BMI became the standard for defining 
obesity and overweight conditions. Its low cost and elimination of the need for 
experts helped make it the right tool for the job. Following national patterns of 
narrowing the range of what counts as normal, these thresholds were lowered in 
the 1990s so that more people are be diagnosed as overweight and at risk for 
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obesity and comorbidities that accompany it. Second, this chapter also highlights 
how the momentum gained during the 1990s and intentional lobbying efforts 
aided in the flattening of BMI from a screening tool effectively elevating it to a 
health indicator. With disease status recognition in 2013, BMI now has the power 
to determine the “healthy” and the sick. 
This chapter also shows how BMI’s limitations have been routinely 
acknowledged by the scientific community without dismantling the scientific 
enterprise. Scientists understand the limitations of BMI as a predictor of an 
individual’s health, but believe that accumulated adipose tissue is problematic to 
health regardless of the tool that defines it. For them, BMI is a screening tool that 
may or may not be useful for a given individual. Where the expertise lies, then, is 
in determining when BMI is an appropriate tool and when it is not (interview 
data). But this acknowledgment of BMI’s utility is a double-edged sword. 
Because of their pragmatic approach to its usage, researchers are blind to the 
framing power BMI has on their work. The examples of the MHO and the 
obesity paradox highlight such framing power. Because researchers expect to see 
that obesity is always problematic, the unexpected results found in these two 
populations have caused conflict within the community. Again we see how 
scientists are social beings. They are, as is their research, influenced by meta-level 
framing of the obesity epidemic.  
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Chapter 4: Rethinking Obesity: Consequences of Biomedicalization 
 
The “crux” of biomedicalization theory as Clarke and colleagues (2010) write, is 
that “biomedicine broadly conceived is today being transformed from the inside 
out through old and new social arrangements that implement biomedical, 
computer, and information sciences and technologies to intervene in health, 
illness, healing, the organization of medical care, and how we think about and 
live ‘life itself’” (2010, p. 2). My analysis of the trajectory of obesity research 
certainly exhibits the transformations indicative of biomedicalization, offering a 
case study in which a problem that could have been addressed otherwise has 
been reconfigured by the forces of biomedicalization. This concluding chapter 
outlines the political, economic, and social consequences of the biomedicalization 
of obesity. 
4.1 Navigating Disease Status 
During a keynote session at ObesityWeek 2014, two prominent researchers were 
challenged to a mock debate on whether obesity should or should not be labeled 
a disease. The session was held at the close of the day, a time when the sessions 
were usually scarcely attended. But for this debate, the room was packed. Unlike 
the silos that existed at ObesityWeek described in Chapter 2, the room was 
packed with researchers from across all fields:, bariatric surgeons and nurses, 
policy makers, public health researchers, and even pharmaceutical 
representatives. But what ensued over the next hour was not really a debate. 
That is, neither researcher seriously engaged the idea that obesity was not a 
disease. The speaker arguing against disease status, an internist who now works 
in an obesity clinic, acknowledged at the beginning that while he would try to 
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make claims for the sake of debate, he did believe obesity was a disease. It was a 
belief shared by almost everyone in the audience. Over the sixty minutes, it was 
clear that among those in the field of obesity research, there remains no debate 
about whether obesity is or is not a disease, but instead that anyone who denies 
its disease status was not only foolish, but also inflicting harm to the millions of 
obese Americans seeking medical care. When the audience asked questions at the 
end, an outraged researcher was applauded when comparing the obesity 
epidemic to the AIDS epidemic while a Harvard medical anthropologist was 
condemned for her attempts to introduce a point about some potential negative 
consequences that accompany the disease label. 
 When I began this research, a question at the heart of this project asked 
“how do obesity researchers navigate the framing of obesity as a disease and as 
an epidemic?” Through interviews with researchers and analysis of documents 
written by obesity researchers on this topic, it became clear that while scientists 
urged the world to treat obesity seriously,10 they also felt the need to distance 
themselves from the politicization of the obesity epidemic particularly because 
the many disciplines within the field—primarily the traditional medical 
disciplines—continue to fight for legitimacy within the scientific community and 
with the broader public. The researchers I interviewed articulated various 
                                            
10 The Obesity Society (TOS) launched the “Treat Obesity Seriously” campaign in May 2013. 
Through this effort, the TOS targets policymakers to “improve access for obesity treatment so 
those affected can get the same necessary medical care and treatment coverage that’s available 
to all others who suffer from other chronic diseases.” It also directly targets physicians and 
potential patients. Clinicians are encouraged to register for the campaign and receive a BMI 
prescription pad, a poster for their office waiting area that reads “Obesity is a serious disease,” 
and a BMI wheel calculator for the waiting room (TOS, 2013). 
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reasons to support why the disease label mattered, but they varied as to the 
impact this would have within the medical community.  
People who supported that decision, which includes me, agree that 
labeling obesity a disease has a number of potential benefits such as 
recognizing it as a serious medical issue that needs to be treated as 
legitimate care, which it is in some institutions but not others, also 
diseases have a different regulatory framework that encourages drug 
development.  
 
Similarly, a clinical psychologist echoed the economic advantage of disease 
status: 
It does matter, and I think it may matter more over time because obesity, 
as an entity, has never qualified for insurance reimbursement. And of 
course you can see a lot of self-interestedness of obesity researchers and 
clinicians deciding, “OK, it’s a disease.” So, yeah, it could matter in terms 
of reimbursement, which could actually help people. But it could have a 
downside, if people think of their condition as a disease process. They 
may feel 1) more stigmatized, maybe, and 2) they may feel more helpless 
about changing that status. But if it makes it easier for people to get 
treatment and it makes us more socially focused on prevention, then it 
will have a beneficial effect.  
 
For the most part, researchers distanced themselves from discussing how it 
impacts their own research and stakeholder positions. As this endocrinologist 
claims, disease status matters more to outsiders than to insiders. 
Well there is reality and there is perception. I think the reality is that it’s 
not a major thing. The perception is that it is the American Medical 
Association, which represents physicians of the US, and when they make 
a resolution it should be taken very seriously…. so it’s the power of the 
name. I think the perception shows the power of the AMA, that’s really 
the value of it. The name lends legitimacy.  
 
These researchers view their profession as detached from the economic and 
political implications, despite that scientists within the profession have really 
lobbied for these advancements (Boero 2013; interview data).  
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Despite efforts among members of the obesity research community to 
depoliticize disease status within the scientific community, we must attend to the 
direct political and economic implications disease status affords. By labeling 
obesity a disease, insurance companies, the government, and physicians are 
pressured to treat obesity differently. Instead of viewing it as a lifestyle issue, 
drug development is encouraged. In an important white paper published by The 
Obesity Society supporting disease designation, Allison et al. (2008) wrote,  
[t]he FDA would come under more pressure to approve obesity drugs, 
and physicians would be more likely to use obesity drugs in treatment. 
Diseases are often viewed as alterations of normal biochemistry, and or 
many other diseases these alterations are treated with drugs because 
drugs change biochemistry. There likely would be an increased attention 
to development of new and better drugs by pharmaceutical companies 
but also a new willingness of physicians to try obesity drugs. 
 
Disease status for obesity effectively signifies a commitment to the 
biomedicalization of obesity—it confirms commitment to make the individual 
the site of intervention rather than obesogenic environments, encourages 
pharmacotherapy research and development, and prioritizes treatment above a 
commitment to prevention. 
Though most researchers I interviewed belittled the economic and 
political implications entangled with disease status, it is clear that those who lead 
efforts to organize the science and lobbied during the 1990s and 2000s recognized 
what disease status signifies. As highlighted in Chapter 2, obesity researchers 
were heavily engaged in efforts advocating and lobbying for policy change 
including publishing comprehensive guidelines for the treatment of obesity in 
1995, the inclusion of obesity as a leading health indicator in the 2000 publication 
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of Healthy People 2010, and for medical insurance coverage for obesity treatment, 
Medicare and Medicaid, and considered a tax deductible expense (Boero, 2013; 
interview data; Oliver, 2006). 
  Achieving disease status, then, perhaps marks the both the height of the 
obesity epidemic and “success” for the obesity scientific social movement. In 
essence, it is the achievement Dr. George Bray and Dr. Allan Howard envisioned 
nearly fifty years ago: to transform the treatment of obesity as a simplistic, 
lifestyle issue to one that requires intensive, biomedical intervention. Disease 
status marks obesity’s recognition as a topic of legitimate scientific inquiry. It 
marks global recognition that obesity is a complex entity, entangled with social, 
behavioral, physical environments, but one that can be solved by turning inward 
and declaring obesity as a medical—not a social—problem.  
4.2 Dangers of Biomedicalization 
 
In the preceding chapters, I have attempted to place the foregrounding power 
relations at the center of this analysis. Utilizing situational analysis, this project 
directly engages the individual actors, institutions, and non-human actants that 
have been involved in the mobilization and formation of the scientific enterprise 
of obesity research.  
Chapter 2 articulated the field formation of obesity research, highlighting 
rhetorical strategies of multidisciplinarity and complexity to establish obesity 
research as a legitimate scientific field. According to researchers I interviewed, 
the fight for legitimacy continues, though arguably disease designation in 2013 
marked success within the scientific community. The formation of obesity 
research as a multidisciplinary field does pose obstacles for researchers and 
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results in conflict over how to best prevent and manage obesity, highlighting the 
limits of such rhetorical strategies.  
In Chapter 3 I asked questions that position us to move beyond BMI and 
toward thinking about obesity and adiposity differently and to understand the 
dangers that technologies of standardization pose for our societal 
understandings of health. I investigated how scientists understand BMI as a tool 
and ascribe meaning to it in their work, and analyzed how its strong framing 
influences researchers’ ability to interpret their research. Returning to 
biomedicalization literature, this concluding chapter attends to the social justice 
implications of this work.  
Building on the claims made in the preceding chapters, Chapter 4 brings 
forward three main conclusions that have implications not only for how we 
understand the relationship between weight and health, but also for how we 
conceptualize health justice more broadly. Through content analysis, in-depth 
interviews with obesity researchers, and participant observation, I contend that 
BMI has served as a crucial tool for the field of obesity science to stabilize work 
across its multiple disciplines, standardize research and bodies, and to articulate 
adiposity’s risks and health complications. Second, I argue that obesity’s framing 
as complex enables scientists to defend abnormalities in research findings 
without disrupting the BMI paradigm and to justify continued research 
investment and diversification of the field. Finally, “Beyond BMI: 
Conceptualizing Health in the ‘Obesity Epidemic’” argues that meta-level 
framing of the obese condition as a health problem impacts obesity researchers' 
willingness to accept more complex relationships between obesity and health  
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 In the time since the AMA designated obesity a disease, little has changed. 
Though obesity may have faded from the spotlight and most reports conclude 
that incidence rates have somewhat subsided and prevalence remains static, the 
obesity research agenda continues to expand. Since the start of 2014 alone, the 
International Journal of Obesity dedicated a special issue to fetal programming 
and the factors that influence offspring obesity, the IOM and NIEHS hosted a 
two-day conference on environment and obesity interaction, and the FDA is 
expected to pass three new pharmacotherapy options in the coming year. 
 As mentioned in the preceding chapters, scientists problematized obesity 
even before current practices of standardization existed, an emerging scientific 
community was formed, or billions of dollars were channeled to scientific obesity 
research. As George Bray (1990) wrote in an anniversary issue of the 
International Journal of Obesity, “obesity has always been with us.” While he 
was articulating the obesity as a problem has always been with us, we can take 
this to represent the medical perspective on obesity. That is, within the medical 
domain, fatness has never been considered acceptable (Bray, 1979; Bray, 2015). 
Fatness as an undesirable condition has been in the process of medicalization 
since at least the turn of the 20th century, when researchers began studying the 
metabolic causes of increased adiposity. The biomedicalization of obesity at the 
turn of the 21st century, then, is perhaps just the next phase consistent with 
broader trends in medicine (Clarke et al., 2003). The continued push toward 
biomedicalization in obesity research—and away from societal level 
interventions—is dangerous. If the goal of obesity research is to end the “obesity 
epidemic,” biomedical interventions will be insufficient particularly in the 
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context of increasing health disparities in the US. The populations most affected 
by obesity are the same populations that experience adversity in daily life. 
 Perhaps the most dangerous aspect of biomedicalizing obesity is the way 
it sidelines and obscures  preventative efforts like the ones that public health 
researchers advocate. These efforts are not preventative in a risk surveillance 
sense, but rather preventative in that they seek to change the food and built 
environments that adversely impact our health. The societal level changes that 
would need to take place in order to restructure our food market, built 
environments, and stressors are incompatible with an ever-increasingly 
commodified health market. Such reform would challenge us to reconceptualize 
the relationship between weight and health differently, rather than flattening the 
definition health to BMI values that enable patients to access certain treatments. 
Yet in the face of a growing economic sector in biomedical sciences, this seems 
unlikely. Hence, as discussed in chapters 2 and 3, the public health agenda that 
seeks to reform environments often concedes to provide tool kits for individual 
behavioral change. 
But even beyond this, all obesity researchers accept that obesity is a health 
problem and that current schemes of categorization are acceptable. In their “war 
on obesity” they reinforce notions of idealized bodies that erase difference and 
stigmatize those who do not fit within desirable categories. That is, as society 
treats obesity more and more as a problem that must be addressed at individual 
levels, it shuts down opportunities to change the environments that make 
marginalized classes and races sick. The framing power of BMI in obesity 
research inhibits a more robust conceptualization of health: as the definition of 
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normal, healthy weights continues to shrink, emphasis is focused more directly 
on fixing deviant individuals rather than embracing human difference. 
Effectively, BMI’s usefulness as a stabilization tool within the field of research 
has had far reaching consequences in society that have reinforced and 
reproduced class and race health inequalities.  
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